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Abstract 
 
Background: Physical activity (PA) has been shown to improve prostate cancer 
survivors physical functioning and quality of life (QoL). Purpose: To investigate the 
impact of a community-based PA program on the QoL, fitness, fatigue, strength, and 
physical functioning of prostate cancer survivors, with a secondary purpose to examine 
the program’s feasibility and sustainability. Methods: PROFit, a 12-week community-
based, supervised PA program was developed by reviewing the current PA and cancer 
literature, and through establishing partnerships with a cancer care program, community 
fitness facility, and university. Specifically, 15 prostate cancer survivors and their 
partners (N=4) were recruited to take part in the PA program, which consisted of strength 
(i.e., circuit training) and aerobic training. Survivors QoL, fatigue, prostate cancer 
specific symptoms, physical functioning, and PA levels were assessed at baseline, six and 
12-weeks. Program attendance and cost were recorded to determine feasibility and 
sustainability. Satisfaction surveys were administered to participants and partners at six 
and 12-weeks. Results: One-way repeated measures analysis of variance found 
significant increases in lower body strength across all time points and flexibility from 
baseline to 12 weeks. No significant improvements were found in upper body strength, 
agility, aerobic fitness, weekly moderate-vigorous PA, QoL, and fatigue; however, non-
significant increases in participant upper body strength, weekly moderate-vigorous PA, 
and agility were noted. Participants and partners reported a high level of satisfaction with 
the program, and program attendance and intervention costs were satisfactory. 
Conclusion: The PROFit program had a positive impact on prostate cancer survivorship. 
Due to the lack of evidence surrounding community-based PA programs in prostate 
cancer survivors, the PROFit program delivers valuable insight into the collaboration 
between hospitals, universities and community centers to provide prostate cancer 
survivors with a resource for improving survivorship (i.e., QoL, physical functioning) 
following treatment. 
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Chapter 1: Introduction 
 
1.1 Background 
 
Cancer is the leading cause of death in Canada, accounting for approximately 30% 
of all deaths annually (Canadian Cancer Society’s Advisory Committee on Cancer 
Statistics [CCSACCS], 2017). In 2017, it was estimated that 206,200 Canadians would be 
diagnosed with cancer, and 80,800 will die from the disease (CCSACCS, 2017). The 
greatest percentages of Canadians (i.e., 90%) who develop cancer are over the age of 50 
and, given the aging population, the number of new cancer cases is expected to double in 
those 65 years of age and over (CCSACCS, 2017). Fortunately, cancer is not a death 
sentence as it once was believed to be (Reb, 2007). The five-year relative survival ratio 
for all cancers has risen to 60% (CCSACCS, 2017). These improvements can be 
attributed to advances in cancer screening procedures and treatment options (Siegel et al., 
2012).  
Improved survival rates in Canada have created a growing population of cancer 
survivors (CCSACCS, 2017; Jefford et al., 2013), and it is estimated that there are 
approximately 1 million cancer survivors currently in Canada (CCSACCS, 2017). A 
cancer survivor is defined as a person at any stage of cancer care, from diagnosis to long-
term survival (Siegel et al., 2012). The term survivorship includes the physical and 
psychosocial outcomes of a cancer diagnosis and treatment (Dow, 2003). Despite the 
increase in survival rates, many cancer survivors experience long-lasting physical and 
psychological side effects as a result of their cancer and treatments. Short-term side 
effects such as nausea, vomiting, fatigue, and pain can appear immediately following 
treatments (Courneya & Friedenreich, 2007); while other long-term side-effects including 
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muscular atrophy, loss of bone density, increases in adipose tissue and psychosocial 
concerns (i.e., anxiety and depression) have been identified by cancer survivors much 
later (CCSACCS, 2017; DeSantis et al., 2014). Some adverse effects, such as fatigue and 
fear of cancer reoccurrence have been found to persist for months, and even years 
following cancer treatments (Resnick et al., 2013). The short- and long-term adverse 
effects experienced by cancer survivors’ can significantly impact their quality of life 
(QoL) and physical functioning (Ferrer, Huedo-Medina, Johnson, Ryan and Pescatello, 
2010; Irwin, 2013; Schmitz et al., 2010). As such, strategies to improve cancer 
survivorship are warranted. Research exploring the role that physical activity (PA) and 
exercise plays in improving survivorship has grown in the past few decades (Speck, 
Courneya, Masse, Duval and Schmitz, 2010), and has found that engaging in regular PA 
can help cancer survivors manage the side effects, as well as promote overall health 
(Mishra et al., 2012; Rock et al., 2012). 
1.2 Physical Activity and Cancer 
 
In the last several years there has been a surge in PA and cancer research. The 
research has clearly determined that PA is safe and feasible for cancer survivors, and 
participation in PA has been found to improve overall health and QoL, and lower 
mortality rates (Brown et al., 2011; Ferrer et al., 2010; Fong et al., 2012; Mishra et al., 
2012; Speck et al., 2010). In a meta-analysis, Fong et al. (2012) reviewed 34 randomized 
controlled trials that explored the effects of PA in various cancer survivor groups who had 
completed cancer treatment, and established that PA improved body composition (i.e., 
BMI), QoL, psychological outcomes (e.g., fatigue, depression), as well as physical 
functioning (e.g., aerobic capacity, peak power output) and physiological (e.g., strength) 
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outcomes. It was also noted by Fong and colleagues (2012), that in studies that combined 
both aerobic and resistance training there were significantly larger improvements in the 
physical and functional well-being of survivors compared to studies that used aerobic 
exercise alone. These findings are supported by similar studies showing improvements in 
fatigue (Brown et al., 2011), physiological fitness including strength and aerobic capacity 
(Speck et al., 2010) and QoL (Mishra et al., 2012) in cancer survivors. Furthermore, PA 
interventions implemented during and after treatment can produce these beneficial effects 
during various stages of their cancer trajectory (Mishra et al., 2012; Speck et al., 2010). 
Improvements in physical functioning and fatigue following PA interventions have led to 
a higher QoL both during and after treatment in cancer survivors (Ferrer et al., 2010).  
Adopting a physically active lifestyle has shown significant promise in cancer 
survivors returning to an optimal QoL once treatments are finished (Fong et al., 2012). 
Despite the benefits of PA for cancer survivors, many are insufficiently active to achieve 
such health benefits. Research has found that 22.6% of cancer survivors in complete 
remission and 17.8% of cancer survivors currently with cancer are active (Coups & 
Ostroff, 2005; Neil, Gotay and Campbell, 2014), meaning that the greatest proportion of 
cancer survivors do not participate in the recommended levels of PA. This is distressing, 
especially when considering that cancer survivors have been shown to express an interest 
in PA programs (Wong, McAuley and Trinh, 2018). Experts in PA and cancer research at 
The American College of Sports Medicine (ACSM) and the American Cancer Society 
(ACS) have developed PA guidelines for cancer survivors (Schmitz et al., 2010). 
Guidelines state that cancer survivors should engage in at least 150 minutes of moderate-
to-vigorous PA per week (Buffart, Galvao, Brug, Chinapaw and Newton, 2014; Schmitz 
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et al., 2010), and incorporate strength-training exercises to improve physical fitness, 
reduce the likelihood of comorbidities (e.g., cardiovascular disease, type 2 diabetes), and 
enhance QoL (Mishra et al., 2012). As stated by Schmitz and colleagues (2010), cancer 
survivors should avoid inactivity and be as active as their condition allows; unfortunately, 
the effects of cancer treatments can make it difficult to begin and maintain a PA routine 
(Irwin, 2009). Given these findings, PA interventions including aerobic and resistance 
training exercises are an effective and feasible non-pharmaceutical approach to improve 
cancer survivors’ physical and psychological health. 
1.3 Prostate Cancer and its Side Effects 
 
In 2017, prostate cancer was the most commonly diagnosed form of cancer in 
males, reflecting nearly 21% of all male cancer cases (CCSACCS, 2017). Fortunately, 
due to improvements in early detection (Stattin et al., 2014) and treatment options 
(Thorsen, Courneya, Stevinson and Fossa, 2008), prostate cancer has a five-year relative 
survival rate of 95% (CCSACCS, 2017), meaning that a large portion of men will survive 
their cancer diagnosis. Treatment options are considered based on prognostic factors, 
including the stage of the cancer (i.e., where the primary tumor is), and age (Keyes et al., 
2013). Common treatment options include chemotherapy, radiotherapy, hormonal therapy 
such as Androgen Deprivation Therapy (ADT), and surgery. Surgery to remove the 
prostate is a commonly used treatment for otherwise healthy men under the age of 70 
(Keyes et al., 2013). Radiotherapy can be used in the early stages of prostate cancer, but 
is usually combined with other treatments in the later stages to improve survival (Segal et 
al., 2009), while chemotherapy may be used to control or delay symptoms (ACS, 2016). 
Hormonal therapies (i.e., ADT) aim to reduce the levels of androgens in the body to 
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prevent the size of cancerous cells in and around the prostate from growing (Alibhai et 
al., 2010). Advancements in treatment options can increase survival; however, the 
adverse side effects from treatment may have negative consequences even years after 
treatment is completed. Treatment-related symptoms can vary depending on the types and 
stages of cancer involved and how they impact health-related QoL (Mystakidou et al., 
2013). 
Prostate cancer treatment can lead to short- and long-term side effects. Side 
effects range from psychological trauma, including depression, stress, anxiety, and a loss 
of self-control, to physical symptoms, such as decreased muscular strength, diminished 
cardiovascular function, and increased fatigue, nausea, and pain (Courneya & 
Friedenreich, 1999; Krupski & Litwin, 2007; Thorsen et al., 2008). There are varying side 
effects associated with each treatment for prostate cancer. For example, ADT can result in 
increased fatigue, sexual dysfunction, anemia, loss of bone density, and muscular atrophy 
(Gardner, Livingston and Frazer, 2014; Higano et al., 2003; Alibhai et al., 2010). The side 
effects of cancer treatment are generally short-term, such as an increased level of fatigue 
immediately following radiation therapy (Segal et al., 2009). However, late-appearing 
side effects may persist for months or even years after completing prostate cancer 
treatments (Resnick et al., 2013). Increases in fat mass, decreases in lean body mass, and 
increased fatigue levels have been found within 3-12 months’ post-treatment (Alibhai, 
Gogov & Allibhai, 2006; Basaria et al., 2002; Gardner et al., 2014), and declines in 
sexual, urinary, and bowel function can last up to 15-years following treatment (Keyes et 
al., 2013; Resnick et al., 2013; Thorsen et al., 2008). In turn, these physical side effects 
have been found to significantly influence psychological health, leading to a diminished 
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QoL, and an increased risk of anxiety and depression (Thorsen et al., 2008). In fact, men 
have reported sexual incontinence and long-term bowel and urinary dysfunction as a 
significantly diminishing factor in their overall QoL (Davis et al., 2014; Ferrer et al., 
2013).  
A cancer diagnosis and course of treatment can be out of an individual’s control; 
however, there are behavioral strategies that can help cancer survivors regain control of 
their perceptions and ability to cope (Karvinen, Courneya, North and Venner, 2007). 
Studies have shown significant improvements in prostate cancer survivors’ QoL and 
physical fitness through participation in PA programs (Thorsen et al., 2008), and this area 
of research is gaining considerable attention. 
1.4 Physical Activity and Prostate Cancer 
 
 Physical activity has been shown to improve many of the negative side effects of 
prostate cancer treatments (Bourke et al., 2016). In a review by Thorsen et al. (2008), the 
authors investigated the effects, prevalence, and determinants of PA on health outcomes 
in prostate cancer survivors.  The results indicated improvements in body composition, 
flexibility, muscular strength, QoL, and fatigue with increased levels of PA. A review by 
Gardner et al. (2014) examined exercise and treatment-related side effects in prostate 
cancer patients and provided support for these findings. As mentioned in the review, 
using some form of aerobic and/or resistance training exercises can lead to improvements 
in the adverse effects of prostate cancer treatments, such as increases in muscular strength 
and endurance, and mitigating levels of fatigue. Given these findings, incorporating 
aerobic and resistance exercises into PA and exercise interventions can provide a great 
benefit to prostate cancer survivors’ physical and psychological health. Unfortunately, 
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less than half of the total population of prostate cancer survivors are sufficiently active 
and have difficulty maintaining a regular PA routine (Thorsen et al., 2008). Research 
continues to encourage prostate cancer survivors to adopt or continue a physically active 
lifestyle (Baumann, Zopf & Bloch, 2012), and a study by Segal et al. (2009) provides a 
list of specific precautions to be considered (i.e., risk of bone fractures due to hormone 
therapy) when creating PA and exercise programs for prostate cancer survivors. Any PA 
programs should be modified to accommodate these precautions, but overall survivors 
should aim to be as active as possible to receive the greatest benefit. 
While individual training programs have been shown to be an effective method of 
exercise prescription in prostate cancer survivors (Galvao et al., 2006), group-based (i.e., 
participants exercising together at the same time) programs have also been found to 
improve physical fitness, functional performance, QoL, and fatigue levels (Keogh & 
MacLeod, 2012; Segal et al., 2009). In addition, exercising in groups can provide greater 
social supports and camaraderie between participants (Haas & Kimmel, 2011). PA 
interventions have typically been conducted in a research setting with limited 
transferability to a ‘real-world’ environment. In recent years, the use of community-based 
PA programs and their effect on the physical fitness and QoL of cancer survivors has 
been studied by researchers with promising results (Cheifetz et al., 2014). Through 
collaboration between fitness and research facilities, community-based PA programs have 
the potential to be a sustainable and effective resource for increasing PA levels in cancer 
survivors.  
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1.5 Community-Based Physical Activity for Cancer Survivors 
 
Few studies have examined the effects of community-based PA and exercise 
programs in cancer survivors, but some differences between community-based and other 
forms of unsupervised PA (e.g., home-based) have been discussed. Santa Mina et al. 
(2018) identified the benefits of supervised, group-based PA for cancer survivors in 
fitness facilities, including stronger social supports, and improved program adherence and 
physical functioning, when compared to unsupervised PA programs. The study also 
suggests that providing the option of community-based PA program for cancer survivors 
is an important addition to the continuum of cancer-related care, allowing survivors to 
continue with their PA-related needs. Potential benefits of incorporating PA in a 
community-based setting have been explored in recent studies. Improvements in fatigue, 
physical functioning (i.e., flexibility and muscular strength), mental health (i.e., anxiety), 
and social supports were found in cancer survivors participating in a 12-week 
community-based exercise program at the YMCA (Rajotte et al., 2012). Similar results 
were found in another community-based exercise program of the same duration and 
location by Foley, Barnes and Hasson (2015), with significant improvements in physical 
functioning and emotional, functional, and total well-being. The exercises in both studies 
were completed in small groups - an important aspect of the community-based approach. 
Group-based activity has been shown to benefit QoL and physical functioning in cancer 
patients (Kolden et al., 2002; Mutrie et al., 2007; Segal et al., 2009), while mitigating any 
intimidation towards exercise in a social setting (Haas & Kimmel, 2011). Also, creating a 
PA program for cancer survivors allows participants to connect with each other for social 
support. For example, Foley et al. (2015) incorporated 30 minutes of ‘community 
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building’ time at the end of their exercise session for participants to share personal 
experiences, adding to the beneficial effect of a group-based setting. The high adherence 
rates associated with these community-based PA programs suggest that if more of these 
PA programs were made available, a greater number of cancer survivors would take 
advantage of them (Foley et al., 2015; Haas & Kimmel, 2011; Rajotte et al., 2012).  
A recent example of a community-based exercise and education program targeting 
all people with cancer is CanWell (Cheifetz et al., 2014). The CanWell program was a 12-
week program consisting of weekly exercise sessions including aerobic, resistance, and 
flexibility exercises. Significant improvements were found in overall health-related QoL 
and walking distance, as well as a reduction in the experienced symptoms commonly 
associated with cancer (e.g., pain, fatigue and nausea). CanWell demonstrates how 
collaboration between a cancer center, university, and community institution can create 
successful community-based exercise programs that are not in a research center, which is 
commonly where they take place.  
However, the limitations associated with the CanWell program (e.g., low 
adherence rates) could be attributed to the participant sample including all persons living 
with cancer at different stages of cancer care. The inclusion of participants undergoing 
active treatment can have a negative effect on adherence when compared to other studies 
showing a much greater adherence rate (Foley et al., 2015; Rajotte et al., 2012). This 
suggests examining specific cancer populations (e.g., prostate) at certain stages of cancer 
treatment (e.g., post-treatment) for future studies, while using the CanWell design as a 
useful reference point for creating new community-based PA interventions. Group-based, 
yet individually tailored exercise intervention has been shown to improve participant self-
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efficacy and physical health, and promote sustainability (Campbell, Mutrie, White, 
McGuire and Kearney, 2005), but some types of cancer (e.g., breast) have been more 
heavily researched than others. With the increased number of prostate cancer survivors 
currently living with the adverse effects of cancer treatments, sustainable and effective 
PA programs are needed to improve overall health and well-being. 
1.6 Purpose of Study 
 
The physical/psychological health and QoL of prostate cancer survivors has been 
shown to improve with participation in regular PA. Unfortunately, many prostate cancer 
survivors are insufficiently active, with participation rates as low as 29-30% (Thorsen et 
al., 2008). To generate health benefits, prostate cancer survivors need support to improve 
and maintain PA levels. Community-based PA programs have been shown to improve 
physical functioning and QoL in a social setting that promotes inclusion and adherence 
(Foley et al., 2015; Haas & Kimmel, 2011; Murray et al., 2012). However, there is little 
research investigating the benefits of implementing PA interventions in prostate cancer 
survivors in a community-based setting. By determining if a prostate cancer survivors 
QoL and physical functioning are benefited through participation in a community-based 
PA program, survivors may be more enticed to join a PA program and maintain long-term 
adherence to a physically active lifestyle. Furthermore, the community-based PA program 
should be accessible and sustainable to promote survivor participation. The purpose of 
this study was to examine the impact of PROFit, a community-based PA program on 
QoL, fitness, fatigue, strength, and physical functioning of prostate cancer survivors. The 
secondary purpose was to evaluate the feasibility, sustainability, and satisfaction of the 
PROFit program.  
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1.7 Significance of Study 
 
This study will be a valuable contribution to the current research surrounding PA 
and prostate cancer survivors. If the proposed PA program proves to be effective in: (1) 
improving QoL, (2) reducing levels of fatigue and (3) improving physical functioning, it 
will provide a solid framework for developing community-based PA programming for 
prostate cancer survivors. Additionally, this program may aid in providing social support 
to participants, in the hope of enhancing connections between prostate cancer survivors. 
Understanding the challenges associated with running this program, which includes 
participant adherence and operational costs, will give further insight into the sustainably 
and accessibility of a survivorship program. Healthcare professionals (i.e., oncologists) 
can potentially use this program as a resource to enhance PA in prostate cancer survivors 
who need guidance and in turn, may reduce the use of hospital resources by improving 
survivors’ health.   
1.8 Objectives 
 
• To assess the effect of a community-based PA program on physical functioning, 
strength, fitness, fatigue and QoL in the prostate cancer survivor population.  
• To explore the feasibility and sustainability, and satisfaction, of a community-
based PA program for prostate cancer survivors through program attendance, cost 
of implementing the program, and participant/partner satisfaction surveys. 
1.9 Research Hypotheses 
 
 Based on the results of previous studies examining PA and prostate cancer 
survivors, it is anticipated that participants in the community-based PA program will 
experience improvements in their QoL, improve aerobic and strength training fitness, and 
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have reduced fatigue levels. Also, we anticipate high satisfaction with the PROFit 
program, and evidence of program feasibility and sustainability. 
As a final note, the present dissertation was completed using Memorial 
University’s manuscript format. Included in this dissertation is an introduction (Chapter 
1), review of the relevant literature (Chapter 2), and research manuscript (Chapter 3). 
Based on this formatting some of the information presented in the dissertation may be 
repetitive.   
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Chapter 2 Literature Review 
 
2.1 Cancer in Canada 
 
 Approximately one in two Canadians will be diagnosed with cancer in their 
lifetime and one of four will die of the disease (Canadian Cancer Society’s Advisory 
Committee on Cancer Statistics [CCSACCS], 2017). Cancer is the leading cause of death 
in Canada, accounting for 30% of all deaths (CCSACCS, 2017). In 2017, it was estimated 
that 206,200 Canadians were diagnosed with cancer, and 80,800 Canadians were 
expected to pass away from the disease (CCSACCS, 2017). However, with improvements 
in screening procedures and treatment options, the likelihood of surviving a cancer 
diagnosis has improved in the past few decades (DeSantis et al., 2014). The five-year age-
standardized net survival rate has grown from 53.0% in 1992-1994 to 60% in 2006-2008 
(CCSACCS, 2017). In other words, the odds of an individual surviving 5 years after their 
cancer diagnosis is 60%, when compared to the general population. At the beginning of 
2009, there were 810,045 Canadians alive who were given a cancer diagnosis in the 
previous 10 years, and it is estimated that there are over one million cancer survivors 
living in Canada today (CCSACCS, 2017). A cancer survivor is defined as a person at 
any stage of cancer care, from diagnosis to long-term survival (Siegel et al., 2012). With 
the general population continuing to increase in Canada, we can estimate that the number 
of cancer diagnoses will increase as well, leading to an expanding population of cancer 
survivors (CCSACCS, 2017). Hence, it is expected that there will a large number of 
people living with the long-term adverse effects of cancer and its treatment, impacting 
cancer survivorship and quality of life (QoL).  
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2.2 Side Effects of Cancer Treatment 
 
 Improvements in cancer patient survival rates are due in large part to earlier 
detection and advancements in types modalities (DeSantis et al., 2014). DeSantis and 
colleagues discuss various cancer treatments available, including: chemotherapy, surgery, 
radiation therapy and hormone therapy, and treatment plans are based on the type of 
cancer, stage of cancer progression, the cancers’ characteristics, and other individual 
considerations. Treatments can be used alone, or in combination with each other 
depending on the treatment plan. However, the authors also mention that while improved 
survival rates are attributable to successful cancer treatments, survivors may experience 
acute and chronic side effects as a result. The severity and longevity of these side effects 
can vary between treatments. For example, chemotherapy drugs strive to kill the fast-
growing cancer cells, but it damages healthy cells in the process resulting in side effects 
that include: hair loss; fatigue; nausea and vomiting; mouth, gum, tongue and throat 
problems (e.g., sores and infections); constipation; diarrhea; poor appetite; nerve and 
muscle issues (e.g., loss of balance and fine motor coordination), and weight gain 
(American Cancer Society [ACS], 2016). Another commonly used cancer treatment is 
radiation therapy; high-energy particles that destroy or damage cancer cells. The radiation 
can create skin problems (e.g., swollen, blisters, dryness), increase levels of fatigue and 
cause hair loss (ACS, 2016). Like radiation, surgery to remove the cancerous cells creates 
several short-term side effects such as lymphedema, pain, weight changes and fatigue 
(ACS, 2016). Even after treatments are complete and the initial side effects subside, 
cancer survivors may experience a wide range of late-appearing side effects. For example, 
radiation therapy can cause a hardening of the arteries around your heart (i.e., increasing 
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your risk of a heart attack), heart valve damage, and cognitive impairments (ACS, 2016), 
and patients who have undergone surgery can experience sexual dysfunction, 
neuromuscular conditions, impaired lung function, psychosocial concerns, and cancer 
reoccurrence (DeSantis et al., 2014). Other therapies such as chemotherapy and hormone 
therapy have been associated with late-appearing effects like immune suppression, loss of 
bone density and muscular atrophy (ACS, 2016; DeSantis et al., 2014). The appearance of 
these side effects is not always immediately recognizable, but they play a large role in the 
standard of living for survivors. The physical and psychological consequences of cancer 
treatments have been shown to significantly diminish a cancer survivor’s QoL (Ferrer, 
Huedo-Medina, Johnson, Ryan and Pescatello, 2010), and have been known to persist for 
months and even years after treatment (Resnick et al., 2013), making the return to a 
normal lifestyle difficult. 
2.3 Quality of Life and Physical Activity in Cancer Survivors 
 
 Examined in numerous research studies, QoL is a general term used to assess life 
satisfaction; including the physical, social and emotional aspects of an individual’s life 
(Cella & Tulsky, 1993). When associated with some form of disease or health condition, 
the term ‘health-related quality of life’ has been used in research areas surrounding 
clinical populations such as cancer survivors. The importance of an individual’s QoL has 
not gone unnoticed by cancer researchers, and the relationship between treatment side 
effects and QoL has gained considerable attention. Cancer survivors have reported a 
significantly diminished QoL when compared to those who have never been diagnosed 
with cancer (LeMasters, Madhavan, Sambamoorthi and Kurian, 2013). As discussed in a 
review by Mishra et al. (2012), adverse effects from cancer treatments are wide reaching 
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and have a negative impact on the major domains (i.e., physical, psychological) of a 
cancer survivors’ overall well-being. Specifically, survivors have reported 
musculoskeletal issues (i.e., arthritis), hypertension, and impaired lung capacity when 
compared to individuals without cancer (Mishra et al., 2012; Yabroff, Lawrence, Clauser, 
Davis and Brown, 2004). LeMasters et al. (2013) found that survivors of all types of 
cancer reported more activity limitations and poorer health than their cancer-free 
counterparts, and specific cancer types were found to experience greater distress than 
others. Colorectal cancer survivors experienced the greatest limitations in activity, and 
prostate cancer survivors expressed greater fatigue when compared to their non-cancer 
controls. Unfortunately, studies have shown these limitations can last for years after their 
diagnosis (Yabroff et al., 2004). In recent years, research exploring the importance of 
physical activity (PA) for cancer survivors has grown. Research has established that PA 
has been found to be safe and feasible for cancer survivors, and leads to beneficial 
improvements in QoL, cancer symptom management, strength, fatigue, depression, and 
physical functioning (Courneya & Friedenreich, 2007). More specifically, compared to 
cancer survivors who are not physically active, those who participate in PA have reported 
greater physical functioning and generally lower levels of symptoms (e.g., fatigue, pain, 
nausea and vomiting; Tang et al., 2016). In addition, PA is associated with reduced all-
cause and cancer-specific mortality (Ballard-Barbash et al., 2012). The benefits of PA 
have been well documented across the cancer continuum, ranging from prevention to 
palliative care (Courneya & Friedenreich, 2007; Ferrer et al., 2010; Friedenreich & 
Orenstein, 2002; Mishra et al., 2012; Newton & Galvao, 2008).  
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 For survivors undergoing active treatment, PA and exercise has been shown to 
improve physical functioning, reduce pain, improve sleep patterns and emotional states, 
such as fatigue, depression, and anxiety (Courneya & Friedenreich, 2007; Mishra et al., 
2012). In an extensive review, consisting of 82 studies (40% of which were conducted 
during active treatment), positive effects were seen in aerobic fitness, muscular strength, 
functional QoL, anxiety and self-esteem (Speck, Courneya, Masse, Duval and Schmitz, 
2010). Of the studies examining PA during active treatment, the majority included 
aerobic interventions (i.e., 88%) at various intensities and frequencies. However, a study 
by Courneya et al. (2007) examining breast cancer patients receiving chemotherapy found 
resistance training provided similar benefits, including improved body composition, 
physical functioning, and muscular strength. This would suggest using some variation of 
PA and exercise (i.e., aerobic or resistance) may produce comparable benefits in cancer 
survivors. In support of this finding, a study by Adamsen et al. (2003) evaluated the 
physical capacity and health benefits of an exercise program that included aerobic and 
resistance exercise in cancer patients undergoing chemotherapy. At the end of the 
program, significant increases were found in aerobic and muscular capacity, as well as 
improvements in QoL and general well-being, when compared to baseline measurements. 
Similar results were found in a home-based aerobic and resistance exercise intervention in 
breast and prostate cancer patients undergoing radiation therapy (Mustian et al., 2009). 
Cancer patients in the exercise group had significantly higher QoL and lower cancer-
related fatigue than the cancer patients in the control group. Furthermore, these 
improvements were found post-intervention and at the 3-month follow-up.  
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Not only have the beneficial effects of PA and exercise been examined in cancer 
patients undergoing treatment, PA has been found to improve QoL in cancer survivors 
once their treatment has ended. In a review by Speck et al. (2010), 60% of the studies 
included examined PA and cancer survivors’ post-treatment, and significant 
improvements in aerobic fitness, upper- and lower-body strength, body fat percentage, 
overall QoL, mood and fatigue were identified. Similar benefits, including improvements 
in physical functioning, psychological outcomes (i.e., reduced levels of fatigue and 
depression) and QoL, were found in an extensive meta-analysis involving PA and cancer 
survivors’ post-treatment (Fong et al., 2012). These findings show the importance of 
adopting and maintaining a physically active lifestyle. In addition, it highlights the 
relationship between the structure of a PA program (i.e., types of exercises included, 
intervention environment) and the PA levels of cancer survivors. For example, 
interventions that are a minimum of 12-weeks in duration, include behavior changing 
techniques (e.g., self-monitoring), and are offered in different settings (e.g., one-on-one or 
group-based) have been found to be effective at promoting PA maintenance (Short, 
James, Stacey and Plotnikoff, 2013). Some PA interventions have additional benefits to 
their design, such as improved social support between participants in group-based PA 
(Haas & Kimmel, 2011), when compared to one-on-one training.  
Due to the positive benefits of PA for cancer survivors, Schmitz et al. (2010) 
recommends cancer patients undergoing non-invasive treatments, such as chemotherapy 
and radiation therapy, to participate in PA. The authors specify that cancer survivors are 
recommended to participate in 150-minutes of moderate-to-vigorous PA (MVPA) per 
week, as well as two days of muscular strength training. Unfortunately, levels of PA in 
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cancer survivors have been shown to decrease following a cancer diagnosis and treatment 
(Neil, Gotay and Campbell, 2014). In Canada, less than 22% of cancer survivors have 
been found to be physically active, with rates as low as 13.8% and 16.6% reported by 
female colorectal and breast cancer survivors, respectively (Courneya, Katzmarzyk and 
Bacon, 2008). Physical inactivity is a major contributor to disease burden and mortality, 
regardless of disease state (Lee et al., 2012), and has been compared to smoking and 
obesity for its harmful effects (Bouchard, Blair and Katzmarzyk, 2015). Finally, 
Courneya, Rogers, Campbell, Vallance, and Friedenreich (2015) found that just over half 
(65%) of cancer survivors meet recommended PA levels post-intervention, suggesting the 
need for a sustainable PA program. Future research studies may wish to consider 
exploring different PA program settings to find beneficial ways of increasing levels of PA 
in cancer survivors. 
2.4 Community-Based Physical Activity Programs for Cancer Survivors 
  
  Although the beneficial effects of PA have been well documented, there is limited 
research examining PA programming offered in a real-life settings and its impact on 
cancer survivors QoL. This gap in the literature creates a disconnect between the positive 
effects (e.g., enhanced QoL and improved physical health) associated with increased PA 
levels (Fong et al., 2012) and the practical application of PA programs for cancer 
survivors. The limited research surrounding community-based programs and cancer 
survivors has found improvements in fatigue, physical functioning (e.g., muscular 
strength and flexibility), and psychosocial outcomes, such as anxiety and social support 
systems (Cheifetz et al., 2014; Haas & Kimmel, 2011; Rajotte et al., 2012). In one of the 
first studies examining a community-based exercise program, Haas & Kimmel (2011) 
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discuss the development of the Cancer Foundation for Life (CFFL). In their study, they 
outlined the various barriers to PA participation that cancer survivors face, such as 
treatment-related adverse effects, intimidation in an exercise environment, and the cost of 
gym membership fees and/or personal trainers. The CFFL was designed by a retired 
oncologist in collaboration with local hospitals, cancer centres and community 
organizations. The exercise program FitSTEPS For Life (FSFL) was created by the CFFL 
as a program that accepts all persons with cancer (regardless of age, cancer type, and 
stage of disease) and consists of supervised aerobic and resistance exercises. Upon 
evaluation of the program, doctor referrals increased from 168 in 2001 to 2,456 in 2010 
and patient encounters increased from 15 in 2001 to 66,017 in 2010, suggesting an 
increased need for the program and positive adherence. A drop-out rate of 50% was 
noted, however, 46% of dropouts were a result of complications from cancer and other 
diseases, new illness or exercising on their own. The development of the FSFL program 
was one of the first programs to address the need for an effective community-based PA 
and exercise program for cancer survivors. Years later, researchers have continued to 
assess the use of community-based PA programs in cancer survivors. In 2008, the 
LIVESTRONGâ foundation at the YMCA (a community fitness facility) partnered with 
a research center survivorship project to create Exercise and Thrive (E&T), an exercise 
program for cancer survivors who had finished treatments. Rajotte et al. (2012) used a 
pre- and post-testing study design to examine the effectiveness and safety of the 12-week 
bi-weekly E&T program with their 221 cancer survivors. The participants completed 
individualized aerobic and resistance training exercises in a group setting while 
supervised by YMCA personal training staff. Their findings indicated improvements in 
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fatigue, physical function (i.e., flexibility, walking endurance and upper and lower body 
strength), musculoskeletal symptoms, mental health, social support and PA levels. In 
addition, adherence rates to the program were high with 88% of participants attending 
more than half of the activity sessions, and program satisfaction was high (>95%). The 
personal trainers monitoring participant exercise received 16 hours of training in cancer 
terminology, staging, treatment options and adverse effects, as well as psychosocial issues 
facing cancer survivors prior to beginning the program. The preparation of the trainers, 
and that the program was offered in 13 different YMCA locations in the region likely 
contributed to its overall success. The LIVESTRONGâ program continued to grow at 
YMCA facilities, serving over 29,000 participants by 2015 (Heston, Schwartz, Justice-
Gardiner and Hohman, 2015). Participants reported their satisfaction with the program 
and the environment of the YMCA. A recent evaluation of the LIVESTRONGâ program 
on cancer survivors PA, fitness, cancer-related fatigue and QoL by Irwin et al. (2017) 
found improvements in all outcomes following participation in the 12-week program. 
Furthermore, this study highlighted the safety of the program through lack of injuries 
reported in the 186 participants, and the requirement of physician consent before 
participants can begin the exercise program. The high adherence rates noted by Rajotte et 
al. (2012) are similar to the adherence rate (81.5%) of adolescents with cancer to a 
community-based PA program designed by Keats & Culod-Reed (2008). Both studies 
demonstrate the feasibility of a community-based PA program for individuals on the 
cancer care continuum.  
An important aspect of these community-based programs is the social setting. 
Improvements in well-being, emotional adjustment, and QoL have been found in cancer 
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survivors after psychosocial interventions or group therapy sessions (Goodwin, 2005; 
Spiegel et al., 2007). Group-based PA and exercise interventions have also been found to 
benefit QoL and physical functioning (Kolden et al., 2002; Mutrie et al., 2007). A recent 
review of home- and community-based PA interventions in cancer survivors by Swartz et 
al. (2017) determined that using group-based PA produces the largest effect sizes in 
respect to physical functioning. Organizing PA interventions for cancer survivors in a 
group-based design can mitigate any intimidation towards exercise and allow survivors to 
connect with one another for support and encouragement (Haas & Kimmel, 2011). 
Furthermore, positive support from family and friends is associated with better physical 
and mental health-related QoL in cancer survivors, suggesting the importance of 
including a partner in community-based PA program to promote confidence in PA 
(Mehnert, Lehmann, Graefen, Huland and Koch, 2010). Murray et al. (2012) examined 
the effect of exercise and psychosocial support using a community-based program on 
QoL and fatigue in 42 cancer survivors. The exercise sessions were conducted two days 
per week by personal trainers, while the psychosocial support group was once per week 
and lead by a licensed clinical social worker. At the end of the 12-week program, there 
were statistically significant improvements found in QoL, as well as a reduction in 
fatigue. The benefits of a psychosocial support group, as the study by Murray and 
colleagues suggests, demonstrates the effectiveness of including a group-based approach 
in future community-based PA programs for cancer survivors.   
In a recent study by Cheifetz et al. (2014), the authors created the community-
based exercise and education program ‘CanWell’ for cancer survivors. The 12-week 
program took place at the YMCA fitness facility and consisted of weekly exercise 
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sessions including aerobic, resistance training, and flexibility exercises, similar to the 
structure of previous community-based PA programs (Haas & Kimmel, 2011; Murray et 
al., 2012; Rajotte et al., 2012). The exercise program was conducted in a social setting 
using individualized exercise prescriptions for each participant, as determined by unique 
cancer type, stage of disease and any contraindications. A total of 139 cancer survivors 
participated in ‘CanWell’ and upon completion of the program, the researchers found 
significant improvement walking ability from baseline to 6 weeks, improved health-
related QoL and a reduction in symptoms experienced from baseline to week 12. These 
findings support the need for programs that are at least 12-weeks in duration, as 
participants’ physical performance improved significantly within the first six weeks, but 
significant improvements in QoL and symptoms were not found until 12 weeks. In 
addition, the ‘CanWell’ program was designed through collaboration between an acute 
care hospital, academic center and a YMCA facility. Previous activity programs created 
for cancer survivors had a similar design (Haas & Kimmel, 2011; Rajotte et al., 2012), 
and demonstrates the success of providing a PA and exercise program for cancer 
survivors through collaboration. The improvements in physical functioning and QoL 
found in the ‘CanWell’ program (Cheifetz et al., 2014) are similar to the results found in a 
more recent study by Foley, Barnes and Hasson (2015). The researchers examined 
physical function and QoL outcomes in 59 cancer survivors who had participated in a 12-
week community-based exercise program. After the completion of the program, 
participants were found to have increased walking capacity, increased functional mobility 
and improved physical, emotional, functional and total well-being. Improvements in 
physical functioning (i.e., mobility, upper and lower body strength, balance, and upper 
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extremity flexibility) and QoL (i.e., emotional, physical, functional, social and total well-
being) were also determined by Foley, Hasson and Kendall (2018) when examining a 12-
week community-based multi-modal exercise program in 52 breast cancer survivors. 
Furthermore, the breast cancer survivors in this study were assigned to an early start 
group (<1 year since completing cancer treatment) and a late start group (>1 year since 
completing cancer treatment) to determine if there was any difference in outcome effects. 
Irwin and colleagues found no significant difference between the early start and late start 
groups in relation to physical functioning and QoL, except for significant improvements 
in the emotional well-being subscale for the early start group compared to the late start 
group. These findings encourage cancer survivors to adopt a physically active lifestyle, 
but some may feel unmotivated to do so, even if they begin immediately after completing 
treatment or more than year later. 
The implementation and impact of community-based PA programs in cancer 
survivors is a growing area of research, and the results of these studies are encouraging. 
However, research surrounding community-based PA programs has typically involved 
cancer survivors in general, creating limitations in the applicability of these results to 
specific cancer populations. As an example, a recent study by Kalter et al. (2015) 
investigated various moderators of the effects of group-based exercise on cancer 
survivors’ QoL and one of the moderators was the type of treatment (i.e., radiation 
therapy and/or chemotherapy). Findings indicated that the effect of the exercise 
intervention on global QoL was larger in cancer survivors who received radiotherapy, or a 
combination of chemoradiotherapy, compared to those who did not. These results suggest 
that cancer treatment modality can moderate the effect of an exercise program on cancer 
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survivors’ QoL. For this reason, it is important to determine what other factors should be 
accounted for when designing an effective community-based PA program (Basen-
Engquist et al., 2017; Courneya et al., 2015). To fill this gap in the research, future studies 
should focus on developing community-based PA programming for specific cancer 
populations (i.e., breast, prostate), and its effect on physical functioning and QoL.   
2.5 Prostate Cancer, Treatment Side Effects and Physical Activity 
 
Prostate cancer is the fourth most common type of cancer, accounting for 10% of 
all cancers diagnosed (CCSACCS, 2017). In males, prostate cancer is the most commonly 
diagnosed type of cancer in Canada, reflecting 21% of all male cancer cases and 
accounting for 21,300 estimated new cancer cases diagnosed in 2017 (CCSACCS, 2017). 
While prostate cancer can occur at any age, the majority of new cancer cases (i.e., 38%) 
occur between the ages of 60-69 (CCSACCS, 2017). When taking into consideration the 
increase in the aging population, this suggests a future increase in the number of prostate 
cancer cases diagnosed each year. Despite being the most commonly diagnosed form of 
cancer in males, the mortality rate in men with prostate cancer is 10%, with a five-year 
relative survival ratio of 95% (CCSACCS, 2017). With an increase in the diagnosis rate 
of prostate cancer accompanied by a lower mortality rate, the result is a large population 
of prostate cancer survivors living in Canada. High survival rates are attributed to 
improvements in screening procedures (Stattin et al., 2014), as well as advanced 
treatment procedures such as surgery, radiotherapy (i.e., external-beam radiation and 
brachytherapy), hormonal therapy (i.e., androgen deprivation therapy [ADT]), and 
chemotherapy (Thorsen, Courneya, Stevinson and Fossa, 2008). In the early 1990’s, the 
advent of prostate-specific antigen (PSA) screening resulted in an increase of men with 
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early-stage prostate cancer, allowing for greater treatment options (Krupski & Litwin, 
2007). Treatment options are considered based on prognostic factors, such as initial PSA 
levels, stage of the cancer (i.e., where the primary tumor is, are regional lymph nodes 
affected, etc.), age, co-morbidities and baseline urinary function (Keyes et al., 2013). 
Surgery to remove the prostate is a commonly used treatment when the cancer is localized 
to the prostate gland (Eton & Lepore, 2002) and for otherwise healthy men under the age 
of 70 (Keyes et al., 2013). Similarly, radiotherapy can be curative in the early stages of 
prostate cancer, but works with other treatments in the later stages to improve overall 
survival (Segal et al., 2009). In advanced stages of the disease, when it has spread from 
the prostate to other areas of the body, hormonal and chemotherapeutic treatments can be 
used to control or delay symptoms (ACS, 2016; Eton & Lepore, 2002). Androgen 
Deprivation Therapy (ADT) is a hormonal treatment that reduces the levels of androgen 
hormones (i.e., testosterone) in the body to prevent cancer cells from growing; patients 
will usually receive ADT for 2-3 years (Alibhai et al., 2010). In some instances, patients 
will receive no immediate treatment at all, and this is typically referred to as ‘active 
surveillance’. Men who are diagnosed with low-risk prostate cancer may opt out of 
immediate treatment, instead they choose to monitor their PSA levels coupled with 
repeated biopsies to determine the rate of progression and when it is necessary to follow 
through with further treatments (Cooperberg, Carroll and Klotz, 2011). Advancements in 
treatment options can increase survival; however, the adverse side effects typically 
associated with treatments can have negative consequences. Treatment-related symptoms 
can vary depending on the types and stages of cancer involved and how they impact 
health-related QoL (Mystakidou et al., 2013).  
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Prostate cancer treatments can lead to short- and long-term side effects. Side 
effects range from psychological trauma, including depression, stress, anxiety, and a loss 
of self-control, to physical symptoms, such as decreased muscular strength, diminished 
cardiovascular function, and increased fatigue, nausea, and pain (Courneya & 
Friedenreich, 1999; Eton & Lepore, 2002; Krupski & Litwin, 2007; Thorsen et al., 2008). 
Different types of treatments can result in variable effects. For example, ADT impacts the 
levels of androgens in the body and in turn, affects the individuals skin, bones, muscles 
and sexual function. ADT can cause increased fatigue, sexual dysfunction, hot flashes and 
anemia (Gardner, Livingston and Frazer, 2014; Higano et al., 2003). Radiation therapy, 
commonly used in combination with other treatments, is associated with increased levels 
of fatigue and skin problems, such as blisters and soreness (ACS, 2016; Segal et al., 
2009). Unfortunately, all treatments for prostate cancer can result in similar effects, such 
as sexual dysfunction and urinary incontinence (Ferrer et al., 2013). Prostate cancer 
patients typically receive at least one form of treatment, or a combination of treatments to 
target the cancerous cells. Short-term side effects occur during or shortly after treatments 
are given. Sadly, short-term side effects may persist for months, or even years, after 
treatments have been completed (Resnick et al., 2013). For example, increased levels of 
fatigue remain 3-12 months after finishing ADT (Alibhai et al., 2006; Stone, Hardy, 
Huddart, A’Hern and Richards, 2000), while declines in sexual, urinary and bowel 
function are common (Keyes et al., 2013; Thorsen et al., 2008) and can last up to 15-years 
following treatment (Litwin, Sadetsky, Pasta and Lubeck, 2004; Potosky et al., 2000; 
Resnick et al., 2013). Declines in uro-genital functioning are common in age-matched 
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men without a history of prostate cancer, however they are more prevalent in prostate 
cancer survivors (Thorsen et al., 2008).  
Different from long-term side effects, some adverse effects are late-appearing, and 
do not begin until after treatments have been completed. For example, within 3-12 
months after initiation of treatment, increases in fat mass (9-11% increase) and decreases 
in lean body mass (2-4% decrease) have been found (Basaria et al., 2002; Gardner et al., 
2014). In prostate cancer survivors especially, a loss of bone density over time due to 
hormonal therapies is common and increases the likelihood of future bone fractures 
(Shahinian, Kuo, Freeman and Goodwin, 2005). Physical side effects have been found to 
significantly influence psychological health, leading to a diminished QoL and an 
increased risk of anxiety and depression (Thorsen et al., 2008). Prostate cancer survivors 
have noted a decline in their QoL during and shortly after treatments, caused in part by 
increased levels of fatigue, urinary incontinence, and sexual and bowel dysfunction 
(Potosky et al., 2004; Sanda et al., 2008). Treatment-related side effects can linger for 
years, continuing to have a negative impact on prostate cancer survivors’ daily activities 
and QoL. As an example, men have reported sexual and bowel dysfunction and urinary 
incontinence as a significantly diminishing factor in their overall QoL for up to 10 years 
after treatments (Davis et al., 2014; Ferrer et al., 2013). Furthermore, prostate cancer 
treatments can lead to feelings of hopelessness, pessimism, and a lack of concentration, 
all of which can reduce participation in activities of daily living (Baumann, Zopf and 
Bloch, 2012). Examination of these short- and long-term side effects and how they affect 
QoL (Davis et al., 2014) provides the basis for developing and implementing behavioral 
interventions in prostate cancer survivors. While many interventions have been explored 
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to alleviate the negative side effects of cancer diagnosis and treatment, especially on QoL, 
one that has gained considerable attention is PA and exercise.  
 Research studies examining the effects of PA interventions in prostate cancer 
survivors has grown in the past decade. PA has been found to reduce the risk of prostate 
cancer specific mortality by 35% and all-cause mortality by 33% in men who exercise ³9-
MET hours per week (i.e., moderate-vigorous PA). In addition, prostate cancer survivors 
who are more physically active post-diagnosis or who have performed recreational PA 
before and after their diagnosis lived longer (Kenfield, Stampfer, Giovannucci, and Chan, 
2011; Friedenreich et al., 2016). Apart from cancer-related mortality, PA has been found 
to improve multiple health outcomes in prostate cancer survivors. A review by Thorsen et 
al. (2008) examined the prevalence of PA and the effects of PA on health outcomes in 
prostate cancer survivors. Of the 16 studies included, the results indicated beneficial 
effects in physical functioning, muscular fitness, fatigue and health-related QoL. Similar 
results were found in a recent review by Bourke et al. (2016), examining the effects of 
exercise for men with prostate cancer across different stages and types of cancer 
treatments. Of the 16 randomized controlled trials included, improvements in submaximal 
fitness, lower body strength, and cancer-specific QoL and fatigue were found. The 
exercise interventions in the review consisted of home-based, supervised, or a mixture of 
the two, suggesting the benefit associated with various forms of exercise interventions. 
Also, as highlighted in the review by Thorsen et al. (2008), many of the studies using PA 
and exercise interventions consisted mainly of resistance training exercises. The effects of 
resistance training in prostate cancer survivors receiving ADT was examined previously 
by Segal et al. (2003). Following a 12-week resistance training program including 155 
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participants, results showed significant improvement in fatigue, health-related QoL and 
upper- and lower-body muscular strength (42% and 32%, respectively) when compared to 
the control group. Standard resistance exercises were used in the study (i.e., leg extension, 
calf raises, leg curl, chest press, bicep curls, overhead press), and the program was 
completed three times per week. Other studies using similar resistance exercise programs 
have produced comparable results, showing significant improvements or some beneficial 
effect on various health outcomes in prostate cancer survivors receiving ADT (Galvao et 
al., 2006; Gardner et al., 2014).  
In addition to resistance exercise, the effects of aerobic exercise in PA programs 
have been investigated using only aerobic interventions or in combination with resistance 
exercises. Aerobic exercise with moderate-to-vigorous intensity has been shown to 
significantly improve walking distance, functional capacity, fatigue levels, and resting 
heart rate (Culos-Reed, Robinson, Lau, O’Connor and Keats, 2007), and prevent 
increases in fatigue commonly experienced during radiation treatments (Windsor et al., 
2004). Segal et al. (2009) conducted a randomized control trial, where 121 men receiving 
radiation therapy for prostate cancer were randomly assigned to resistance exercise, 
aerobic exercise or a control group for 24 weeks. While resistance training improved 
upper- and lower-body strength and QoL, both aerobic and resistance exercise mitigated 
levels of fatigue in participants.  
In prostate cancer survivors, sexual dysfunction is a common long-term side effect 
of radiotherapy and has a detrimental impact on QoL (Sanda et al., 2008). However, 
significant improvements in sexual functioning are found with increases in PA (Dahn et 
al., 2005). Furthermore, increased PA and exercise behaviors result in similar 
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improvements in sexual functioning in men receiving ADT (Cormie et al., 2013; Galvao 
et al., 2010). Since sexual dysfunction has been established as a major contributor to poor 
QoL in prostate cancer survivors, this provides added support for the benefit of PA 
programs in reducing symptoms experienced by survivors and enhancing QoL.  
Improvements in the health-related QoL of prostate cancer survivors has been 
found at various intensities and frequencies of PA. As an example, Phillips, Stampfer, 
Chan, Giovannucci and Kenfield (2015) examined the relationships between different 
intensities and types of activity (e.g., walking, jogging, swimming, weight training, heavy 
outdoor work), and health-related QoL in prostate cancer survivors. Participants reporting 
³5 hours per week of non-vigorous activity and ³3 hours per week of walking had greater 
hormone/vitality scores compared to those reporting <1 hour of each activity, 
respectively. In addition, men who walked at a normal/average or brisk pace had 
improved urinary irritation/obstruction, hormone functioning/vitality, urinary 
incontinence and sexual functioning compared to men who walked at an easy pace. 
Finally, ³90 minutes of normal/brisk walking pace lead to greater hormone/vitality 
scores. The results suggest that engaging in ³240 minutes of walking per week can 
improve hormone functioning and vitality, but 90 minutes of walking at a normal/brisk 
pace per week can be beneficial as well. This is important for prostate cancer survivors 
that want to become more physically active, but may feel they need to engage in large 
amounts of activity to feel any improvement. Varying levels of exercise can help improve 
fatigue, incontinence, muscular strength, aerobic fitness, flexibility and QoL, as 
established in a recent systematic review by Baumann et al. (2012). Furthermore, 
Baumann and colleagues created general exercise guidelines to be considered when 
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implementing PA and exercise in prostate cancer patients. As an example, resistance 
training can begin prior to, during, or shortly after radiation and ADT treatments, and 
should be completed indefinitely two-three times per week, consisting of seven-eight full-
body exercises and six-twelve reps per exercise for two-four sets. These guidelines are 
valuable for future research studies investigating PA and its effects on prostate cancer 
survivors. They provide guidelines about what type, frequency, duration, and intensity of 
exercise should be utilized for optimal benefits.  
Despite these benefits, prostate cancer survivors are insufficiently active with 29-
30% of survivors participating in PA (Thorsen et al., 2008). Keogh et al. (2010) found 
that only 14% of prostate cancer patients on ADT perform one session of strength training 
in a week, less than the recommended two sessions of strength training per week by 
Schmitz et al. (2010). Barriers such as treatment-related side effects, lack of motivation, 
additional comorbidities and an increased age in prostate cancer survivors reduce the 
likelihood that men will participate in PA (Keogh et al., 2014; Ottenbacher et al., 2011). 
Despite these barriers, a recent review by Wong et al. (2018) found that cancer survivors 
are interested in participating in PA programs. The authors even highlight PA preferences 
identified by participants, such as moderate-intensity activity, and supervised versus 
home-based. Elements such as cancer type and level of cancer care could also affect PA 
preferences. Encouragement to adopt a more physically active lifestyle can be provided 
through physicians and other social supports, such as friends and family (Keogh et al., 
2014). It is important that healthcare professionals are given the appropriate tools to 
educate prostate cancer survivors on the benefits of beginning or maintaining PA to 
mitigate treatment side effects and enhance overall QoL, as well as improve long-term 
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prognosis. The likelihood of continuing a physically active lifestyle can be further 
sustained by close supports, such as family, friends and other prostate cancer survivors 
(Thorsen et al., 2008). Future research could investigate the relationship between prostate 
cancer survivors and the effects of a community-based PA program on QoL, fitness and 
function.  
2.6 Rationale and Significance 
 
This study aims to develop a sustainable community-based PA program, with the 
purpose of improving the QoL, physical functioning, and overall survivorship of prostate 
cancer survivors. PA has been shown to consistently improve treatment-related adverse 
effects in prostate cancer survivors, including fatigue, strength, QoL, and physical 
functioning; however, participation in PA among prostate cancer survivors is low (29-
30%; Thorsen et al., 2008).  
In Newfoundland specifically, survivorship has been identified as an important 
gap in the current cancer care model (Easley & Miedema, 2012; Fitch et al., 2009). The 
goals of this study were developed based on the needs identified within the Cancer Care 
Program of Eastern Health. Many prostate cancer survivors request guidance on lifestyle 
issues, such as PA (Ottenbacher et al., 2011), and currently there is no resource to refer 
them to. Community-based PA programs allow prostate cancer survivors to re-connect 
with their community, and represent a ‘real-word’ approach to PA programming through 
collaboration between a cancer centre, an academic center and a fitness facility (Cheifetz 
et al., 2014; Foley et al., 2015). The community-based approach allows for a more 
supportive and cohesive group, which has been shown to improve participant adherence 
to PA (Rajotte et al., 2012). An important factor for a successful community-based PA 
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program is its feasibility and sustainability. This study will provide valuable information 
on the relationship between a community-based PA program designed specifically for 
prostate cancer survivors, and its effect on participants’ survivorship.    
2.7 Objectives 
 
The study sought to further expand the PA and cancer literature by investigating the 
following research objectives: 
1. To examine the effect of a community-based PA program on QoL, fitness, fatigue, 
strength and physical functioning in prostate cancer survivors. 
2. To evaluate the feasibility and sustainability (i.e., dropout rate, reasons for low 
commitment, cost), and participant satisfaction of a community-based PA 
program for prostate cancer survivors. 
2.8 Research Hypothesis 
 
Based on previous research, it was expected that following participation in our 12-
week community-based PA program called ‘PROFit’; we would see improvements in the 
QoL, fitness, fatigue, strength, and physical functioning in prostate cancer survivors, and 
provide support for the feasibility (i.e., adherence rate, retention), sustainability (i.e., cost-
effectiveness) and program satisfaction .  
 
 
 
 
 
 
 
 
 
 
 
 44 
References  
Adamsen, L., Midtgaard, J., Rorth, M., Borregaard, N., Andersen, C., Quist, M., . . . 
Knutsen, L. (2003). Feasibility, physical capacity, and health benefits of a 
multidimensional exercise program for cancer patients undergoing chemotherapy. 
Supportive Care in Cancer, 11(11), 707-716.  
Alibhai, S. M., Breunis, H., Timilshina, N., Johnston, C., Tomlinson, G., Tannock, I., . . . 
Naglie, G. (2010). Impact of androgen-deprivation therapy on physical function and 
quality of life in men with nonmetastatic prostate cancer. Journal of Clinical 
Oncology : Official Journal of the American Society of Clinical Oncology, 28(34), 
5038-5045. doi:10.1200/JCO.2010.29.8091 [doi]  
American Cancer Society. (2016). Treating Prostate Cancer. Retrieved from 
https://www.cancer.org/content/dam/CRC/PDF/Public/8796.00.pdf 
Ballard-Barbash, R., Friedenreich, C. M., Courneya, K. S., Siddiqi, S. M., McTiernan, A., 
& Alfano, C. M. (2012). Physical activity, biomarkers, and disease outcomes in 
cancer survivors: A systematic review. Journal of the National Cancer Institute, 
104(11), 815-840.  
Basaria, S., Lieb, J., Tang, A., & Deweese, T. (2002). Long- term effects of androgen 
deprivation therapy in prostate cancer patients. Clinical Endocrinology, 56(6), 779. 
doi:10.1046/j.1365-2265.2002.01551.x  
Basen-Engquist, K., Alfano, C. M., Maitin-Shepard, M., Thomson, C. A., Schmitz, K. H., 
Pinto, B. M., . . . Fallon, E. (2017). Agenda for translating physical activity, 
 45 
nutrition, and weight management interventions for cancer survivors into clinical and 
community practice. Obesity, 25, S9-S22.  
Baumann, F. T., Zopf, E. M., & Bloch, W. (2012). Clinical exercise interventions in 
prostate cancer patients—a systematic review of randomized controlled trials. 
Supportive Care in Cancer, 20(2), 221-233.  
Bouchard, C., Blair, S. N., & Katzmarzyk, P. T. (2015). Less sitting, more physical 
activity, or higher fitness? Paper presented at the Mayo Clinic Proceedings, , 90(11) 
1533-1540.  
Bourke, L., Smith, D., Steed, L., Hooper, R., Carter, A., Catto, J., . . . Rosario, D. J. 
(2016).    Exercise for men with prostate cancer: A systematic review and meta-
analysis. European Urology, 69(4), 693-703. 
 Canadian Cancer Society’s Advisory Committee on Cancer Statistics. Canadian Cancer 
Statistics 2017. Toronto, ON: Canadian Cancer Society; 2017  
Cella, D. & Tulsky, D. S. (1993). Quality of life in cancer: Definition, purpose, and 
method of measurement. Cancer Investigation, 11(3), 327-336. 
Cheifetz, O., Park Dorsay, J., Hladysh, G., MacDermid, J., Serediuk, F., & Woodhouse, 
L. J. (2014). CanWell: Meeting the psychosocial and exercise needs of cancer 
survivors by translating evidence into practice. Psycho-oncology, 23(2), 204-215.  
Cooperberg, M. R., Carroll, P. R., & Klotz, L. (2011). Active surveillance for prostate 
cancer: Progress and promise. Journal of Clinical Oncology : Official Journal of the 
 46 
American Society of Clinical Oncology, 29(27), 3669-3676. 
doi:10.1200/JCO.2011.34.9738 [doi]  
Cormie, P., R, U. N., D, R. T., Spry, N., Joseph, D., M, A. H., & D, A. G. (2013). 
Exercise maintains sexual activity in men undergoing androgen suppression for 
prostate cancer: A randomized controlled trial. Prostate Cancer and Prostatic 
Diseases, 16(2), 170. doi:10.1038/pcan.2012.52  
Courneya, K. S., & Friedenreich, C. M. (1999). Physical exercise and quality of life 
following cancer diagnosis: A literature review. Annals of Behavioral Medicine, 
21(2), 171-179.  
Courneya, K. S., & Friedenreich, C. M. (2007). Physical activity and cancer control. 
Paper presented at the Seminars in Oncology Nursing, , 23(4) 242-252.  
Courneya, K. S., Rogers, L. Q., Campbell, K. L., Vallance, J. K., & Friedenreich, C. M. 
(2015). Top 10 research questions related to physical activity and cancer 
survivorship. Research Quarterly for Exercise and Sport, 86(2), 107-116.  
Courneya, K. S., Segal, R. J., Mackey, J. R., Gelmon, K., Reid, R. D., Friedenreich, C. 
M., . . . Lane, K. (2007). Effects of aerobic and resistance exercise in breast cancer 
patients receiving adjuvant chemotherapy: A multicenter randomized controlled trial. 
Journal of Clinical Oncology, 25(28), 4396-4404.  
Courneya, K. S., Katzmarzyk, P. T., & Bacon, E. (2008). Physical activity and obesity in 
canadian cancer survivors. Cancer, 112(11), 2475-2482. doi:10.1002/cncr.23455  
 47 
Culos-Reed, S., Robinson, J. L., Lau, H., O'Connor, K., & Keats, M. R. (2007). Benefits 
of a physical activity intervention for men with prostate cancer. Journal of Sport & 
Exercise Psychology, 29(1), 118. doi:10.1123/jsep.29.1.118  
Dahn, J. R., Penedo, F. J., Molton, I., Lopez, L., Schneiderman, N., & Antoni, M. H. 
(2005). Physical activity and sexual functioning after radiotherapy for prostate 
cancer: Beneficial effects for patients undergoing external beam radiotherapy. 
Urology, 65(5), 953-958. doi:10.1016/j.urology.2004.11.029  
Davis, K. M., Kelly, S. P., Luta, G., Tomko, C., Miller, A. B., & Taylor, K. L. (2014). 
The association of long- term treatment- related side effects with cancer- specific and 
general quality of life among prostate cancer survivors. Urology, 84(2) 
doi:10.1016/j.urology.2014.04.036  
Desantis, C. E., Lin, C. C., Mariotto, A. B., Siegel, R. L., Stein, K. D., Kramer, J. L., . . . 
Jemal, A. (2014). Cancer treatment and survivorship statistics, 2014. CA: A Cancer 
Journal for Clinicians, 64(4), 252-271. doi:10.3322/caac.21235  
Easley, J., & Miedema, B. (2012). Rehabilitation after breast cancer: Recommendations 
from young survivors. Rehabilitation Nursing, 37(4), 163-170.  
Eton, D. T., & Lepore, S. J. (2002). Prostate cancer and health-related quality of life: A 
review of the literature. Psycho-Oncology, 11(4), 307-326. doi:10.1002/pon.572 
[doi]  
 48 
Ferrer, R. A., Huedo-Medina, T. B., Johnson, B. T., Ryan, S., & Pescatello, L. S. (2010). 
Exercise interventions for cancer survivors: A meta-analysis of quality of life 
outcomes. Annals of Behavioral Medicine, 41(1), 32-47.  
Ferrer, M., Guedea, F., Suárez, J. F., de Paula, B., Macías, V., Mariño, A., . . . Aguiló, F. 
(2013). Quality of life impact of treatments for localized prostate cancer: Cohort 
study with a 5 year follow- up. Radiotherapy and Oncology, 108(2), 306-313. 
doi:10.1016/j.radonc.2013.05.038  
Fitch, M., Ristovski-Slijepcevic, S., Scalzo, K., Bennie, F., Nicoll, I., & Doll, R. (2009). 
Cancer survivorship: Creating a national agenda. Canadian Oncology Nursing 
Journal/Revue Canadienne De Soins Infirmiers En Oncologie, 19(2), 55-59. 
Foley, M. P., Barnes, V. A., & Hasson, S. M. (2015). Effects of a community-based 
multimodal exercise program on physical function and quality of life in cancer 
survivors: A pilot study. Physiotherapy Theory and Practice, 31(5), 303-312.  
Foley, M. P., Hasson, S. M., & Kendall, E. (2018). Effects of a translational community-
based multimodal exercise program on quality of life and the influence of start delay 
on physical function and quality of life in breast cancer survivors: A pilot study. 
Integrative Cancer Therapies, 17(2), 337-349.  
Fong, D. Y., Ho, J. W., Hui, B. P., Lee, A. M., Macfarlane, D. J., Leung, S. S., . . . Cheng, 
K. K. (2012). Physical activity for cancer survivors: Meta-analysis of randomised 
controlled trials. BMJ (Clinical Research Ed.), 344, e70. doi:10.1136/bmj.e70 [doi]  
 49 
Friedenreich, C. M., & Orenstein, M. R. (2002). Physical activity and cancer prevention: 
Etiologic evidence and biological mechanisms. The Journal of Nutrition, 132(11), 
3456S-3464S.  
Friedenreich, C. M., Wang, Q., Neilson, H. K., Kopciuk, K. A., McGregor, S. E., & 
Courneya, K. S. (2016). Physical activity and survival after prostate cancer. 
European Urology, 70(4), 576-585.  
Galvao, D. A., Nosaka, K., Taaffe, D. R., Spry, N., Kristjanson, L. J., McGuigan, M. R., . 
. . Newton, R. U. (2006). Resistance training and reduction of treatment side effects 
in prostate cancer patients. Medicine & Science in Sports & Exercise, 38(12), 2045-
2052.  
Galvão, D.,A., Taaffe, D. R., Spry, N., Joseph, D., & Newton, R. U. (2010). Combined 
resistance and aerobic exercise program reverses muscle loss in men undergoing 
androgen suppression therapy for prostate cancer without bone metastases: A 
randomized controlled trial. Journal of Clinical Oncology : Official Journal of the 
American Society of Clinical Oncology, 28(2), 340. doi:10.1200/JCO.2009.23.2488  
Gardner, J. R., Livingston, P. M., & Fraser, S. F. (2014). Effects of exercise on treatment-
related adverse effects for patients with prostate cancer receiving androgen-
deprivation therapy: A systematic review. Journal of Clinical Oncology : Official 
Journal of the American Society of Clinical Oncology, 32(4), 335-346. 
doi:10.1200/JCO.2013.49.5523 [doi]  
 50 
Goodwin, P. J. (2005). Support groups in advanced breast cancer. Cancer, 104, 2596-
2601. doi:10.1002/cncr.21245  
Haas, B. K., & Kimmel, G. (2011). Model for a community-based exercise program for 
cancer survivors: Taking patient care to the next level. Journal of Oncology Practice, 
7(4), 252-256.  
Heston, A., Schwartz, A. L., Justice-Gardiner, H., & Hohman, K. H. (2015). Addressing 
physical activity needs of survivors by developing a community-based exercise 
program: LIVESTRONG® at the YMCA. Clinical Journal of Oncology Nursing, 
19(2)  
Higano, C. S. (2003). Side effects of androgen deprivation therapy: Monitoring and 
minimizing toxicity. Urology, 61(2), 32-38.  
Irwin, M. L., Cartmel, B., Harrigan, M., Li, F., Sanft, T., Shockro, L., . . . Mayer, E. L. 
(2017). Effect of the LIVESTRONG at the YMCA exercise program on physical 
activity, fitness, quality of life, and fatigue in cancer survivors. Cancer, 123(7), 
1249-1258.  
Kalter, J., Buffart, L. M., Korstjens, I., van Weert, E., Brug, J., Verdonck-de Leeuw, I. 
M., . . . Ros, W. J. (2015). Moderators of the effects of group-based physical exercise 
on cancer survivors’ quality of life. Supportive Care in Cancer, 23(9), 2623-2631.  
Keats, R., M., & Culos-Reed, N. (2008). A community- based physical activity program 
for adolescents with cancer ( project TREK): Program feasibility and preliminary 
 51 
findings. Journal of Pediatric Hematology/Oncology, 30(4), 272-280. 
doi:10.1097/MPH.0b013e318162c476 
Kenfield, S. A., Stampfer, M. J., Giovannucci, E., & Chan, J. M. (2011). Physical activity 
and survival after prostate cancer diagnosis in the health professionals follow- up 
study. Journal of Clinical Oncology : Official Journal of the American Society of 
Clinical Oncology, 29(6), 726. doi:10.1200/JCO.2010.31.5226  
Keogh, J. W. L., Shepherd, D., Krägeloh, C. U., Ryan, C., Masters, J., Shepherd, G., & 
Macleod, R. (2010). Predictors of physical activity and quality of life in new zealand 
prostate cancer survivors undergoing androgen- deprivation therapy. New Zealand 
Medical Journal (Online), 123(1325), 20-29. doi:10.1038/bmt.2011.2  
Keogh, J. W. L., Patel, A., Macleod, R. D., & Masters, J. (2014). Perceived barriers and 
facilitators to physical activity in men with prostate cancer: Possible influence of 
androgen deprivation therapy. European Journal of Cancer Care, 23(2), 263-273. 
doi:10.1111/ecc.12141  
Keyes, M., Crook, J., Morton, G., Vigneault, E., Usmani, N., & Morris, W. J. (2013). 
Treatment options for localized prostate cancer. Canadian Family Physician 
Medecin De Famille Canadien, 59(12), 1269-1274. doi:59/12/1269 [pii]  
Kolden, G. G., Strauman, T. J., Ward, A., Kuta, J., Woods, T. E., Schneider, K. L., . . . 
Millbrandt, L. (2002). A pilot study of group exercise training (GET) for women 
with primary breast cancer: Feasibility and health benefits. Psycho-Oncology, 11(5), 
447-456.  
 52 
Krupski, T. L., & Litwin, M. S. (2007). Medical and psychosocial issues in prostate 
cancer survivors. Cancer survivorship (pp. 145-156) Springer.  
Lee, I., Shiroma, E. J., Lobelo, F., Puska, P., Blair, S. N., & Katzmarzyk, P. T. (2012). 
Effect of physical inactivity on major non- communicable diseases worldwide: An 
analysis of burden of disease and life expectancy. The Lancet, 380(9838), 219-229. 
doi:10.1016/S0140-6736(12)61031-9  
LeMasters, T., Madhavan, S., Sambamoorthi, U., & Kurian, S. (2013). A population-
based study comparing HRQoL among breast, prostate, and colorectal cancer 
survivors to propensity score matched controls, by cancer type, and gender. Psycho-
oncology, 22(10), 2270-2282.  
Litwin, M. S., Sadetsky, N., Pasta, D. J., & Lubeck, D. P. (2004). Bowel function and 
bother after treatment for early stage prostate cancer: A longitudinal quality of life 
analysis from capsure. The Journal of Urology, 172(2), 515-519. 
doi:10.1097/01.ju.0000129236.56712.e7  
Mehnert, A., Lehmann, C., Graefen, M., Huland, H., & Koch, U. (2010). Depression, 
anxiety, post-traumatic stress disorder and health-related quality of life and its 
association with social support in ambulatory prostate cancer patients. European 
Journal of Cancer Care, 19(6), 736-745.  
 53 
Mishra, S. I., Scherer, R. W., Snyder, C., Geigle, P. M., Berlanstein, D. R., & Topaloglu, 
O. (2012). Exercise interventions on health-related quality of life for people with 
cancer during active treatment. Cochrane Database of Systematic Reviews, (8)  
Murray, L., Roth, E., Galvin, D., Fisher-Bornstein, M., Heyman, E., Bable, K., . . . Frame, 
A. (2012). The impact of resistive exercise and psychosocial support on quality of 
life and fatigue in cancer survivors via utilization of a community- based program: A 
case series. Rehabilitation Oncology, 30(1), 12-17. doi:10.1097/01893697-
201230010-00002  
Mustian, K. M., Peppone, L., Darling, T. V., Palesh, O., Heckler, C. E., & Morrow, G. R. 
(2009). A 4-week home-based aerobic and resistance exercise program during 
radiation therapy: A pilot randomized clinical trial. The Journal of Supportive 
Oncology, 7(5), 158-167.  
Mutrie, N., Campbell, A. M., Whyte, F., McConnachie, A., Emslie, C., Lee, L., . . . 
Ritchie, D. (2007). Benefits of supervised group exercise programme for women 
being treated for early stage breast cancer: Pragmatic randomised controlled trial. 
BMJ (Clinical Research Ed.), 334(7592), 517. doi:bmj.39094.648553.AE [pii]  
Mystakidou, K., Tsilika, E., Parpa, E., Gogou, P., Panagiotou, I., Vassiliou, I., & 
Gouliamos, A. (2013). Relationship of general self-efficacy with anxiety, symptom 
severity and quality of life in cancer patients before and after radiotherapy treatment. 
Psycho-oncology, 22(5), 1089-1095.  
 54 
Neil, S., Gotay, C., & Campbell, K. (2014). Physical activity levels of cancer survivors in 
canada: Findings from the canadian community health survey. Journal of Cancer 
Survivorship, 8(1), 143-149.  
Newton, R. U., & Galvao, D. A. (2008). Exercise in prevention and management of 
cancer. Current Treatment Options in Oncology, 9(2-3), 135-146.  
Ottenbacher, A. J., Day, R. S., Taylor, W. C., Sharma, S. V., Sloane, R., Snyder, D. C., . . 
. Demark-Wahnefried, W. (2011). Exercise among breast and prostate cancer 
survivors—what are their barriers? Journal of Cancer Survivorship, 5(4), 413-419.  
Phillips, S., Stampfer, M., Chan, J., Giovannucci, E., & Kenfield, S. (2015). Physical 
activity, sedentary behavior, and health- related quality of life in prostate cancer 
survivors in the health professionals follow- up study. Journal of Cancer 
Survivorship; Research and Practice, 9(3), 500-511. doi:10.1007/s11764-015-0426-
2  
Potosky, A. L., Legler, J., Albertsen, P. C., Stanford, J. L., Gilliland, F. D., Hamilton, A. 
S., . . . Harlan, L. C. (2000). Health outcomes after prostatectomy or radiotherapy for 
prostate cancer: Results from the prostate cancer outcomes study. Journal of the 
National Cancer Institute, 92(19), 1582-1592.  
Rajotte, E. J., Jean, C. Y., Baker, K. S., Gregerson, L., Leiserowitz, A., & Syrjala, K. L. 
(2012). Community-based exercise program effectiveness and safety for cancer 
survivors. Journal of Cancer Survivorship, 6(2), 219-228.  
 55 
Resnick, M. J., Koyama, T., Fan, K., Albertsen, P. C., Goodman, M., Hamilton, A. S., . . . 
Penson, D. F. (2013). Long-term functional outcomes after treatment for localized 
prostate cancer. The New England Journal of Medicine, 368(5), 436. 
doi:10.1056/NEJMoa1209978  
Sanda, M. G., Dunn, R. L., Michalski, J., Sandler, H. M., Northouse, L., Hembroff, L., . . 
. Wei, J. T. (2008). Quality of life and satisfaction with outcome among prostate-
cancer survivors. The New England Journal of Medicine, 358(12), 1250-1261. 
doi:10.1056/NEJMoa074311  
Schmitz, K. H., Courneya, K. S., Matthews, C., Demark-Wahnefried, W., Galvao, D. A., 
Pinto, B. M., . . . American College of Sports Medicine. (2010). American college of 
sports medicine roundtable on exercise guidelines for cancer survivors. Medicine and 
Science in Sports and Exercise, 42(7), 1409-1426. 
doi:10.1249/MSS.0b013e3181e0c112 [doi]  
Segal, R. J., Reid, R. D., Courneya, K. S., Malone, S. C., Parliament, M. B., Scott, C. G., . 
. . Wells, G. A. (2003). Resistance exercise in men receiving androgen deprivation 
therapy for prostate cancer. Journal of Clinical Oncology : Official Journal of the 
American Society of Clinical Oncology, 21(9), 1653-1659. 
doi:10.1200/JCO.2003.09.534 [doi]  
Segal, R. J., Reid, R. D., Courneya, K. S., Sigal, R. J., Kenny, G. P., Prud'Homme, D. G., 
. . . Slovinec D'Angelo, M. E. (2009). Randomized controlled trial of resistance or 
aerobic exercise in men receiving radiation therapy for prostate cancer. Journal of 
 56 
Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 
27(3), 344-351. doi:10.1200/JCO.2007.15.4963 [doi]  
Shahinian, V. B., Kuo, Y., Freeman, J. L., & Goodwin, J. S. (2005). Risk of fracture after 
androgen deprivation for prostate cancer. The New England Journal of Medicine, 
352(2), 154-164. doi:10.1056/NEJMoa041943  
Short, C. E., James, E. L., Stacey, F., & Plotnikoff, R. C. (2013). A qualitative synthesis 
of trials promoting physical activity behaviour change among post-treatment breast 
cancer survivors. Journal of Cancer Survivorship, 7(4), 570-581.  
Siegel, R., DeSantis, C., Virgo, K., Stein, K., Mariotto, A., Smith, T., . . . Fedewa, S. 
(2012). Cancer treatment and survivorship statistics, 2012. CA: A Cancer Journal for 
Clinicians, 62(4), 220-241.  
Speck, R. M., Courneya, K. S., Mâsse, L. C., Duval, S., & Schmitz, K. H. (2010). An 
update of controlled physical activity trials in cancer survivors: A systematic review 
and meta-analysis. Journal of Cancer Survivorship, 4(2), 87-100.  
Spiegel, D., Butler, L. D., Giese-Davis, J., Koopman, C., Miller, E., Dimiceli, S., . . . 
Kraemer, H. C. (2007). Effects of supportive- expressive group therapy on survival 
of patients with metastatic breast cancer. Cancer, 110(5), 1130-1138. 
doi:10.1002/cncr.22890  
 57 
Stattin, P., Carlsson, S., Holmström, B., Vickers, A., Hugosson, J., Lilja, H., & Jonsson, 
H. (2014). Prostate cancer mortality in areas with high and low prostate cancer 
incidence. JNCI: Journal of the National Cancer Institute, 106(3)  
Stone, P., Hardy, J., Huddart, R., A&Amp, Apos, Hern, R., & Richards, M. (2000). 
Fatigue in patients with prostate cancer receiving hormone therapy. European 
Journal of Cancer, 36(9), 1134-1141. doi:10.1016/S0959-8049(00)00084-8  
Swartz, M. C., Lewis, Z. H., Lyons, E. J., Jennings, K., Middleton, A., Deer, R. R., . . . 
Goodwin, J. S. (2017). Effect of home- and community-based physical activity 
interventions on physical function among cancer survivors: A systematic review and 
meta-analysis doi:https://doi-org.qe2a-proxy.mun.ca/10.1016/j.apmr.2017.03.017 
Tang, F., Wang, J., Tang, Z., Kang, M., Deng, Q., & Yu, J. (2016). Quality of life and its 
association with physical activity among different types of cancer survivors. PloS 
One, 11(11), e0164971.  
Thorsen, L., Courneya, K. S., Stevinson, C., & Fosså, S. D. (2008). A systematic review 
of physical activity in prostate cancer survivors: Outcomes, prevalence, and 
determinants. Supportive Care in Cancer, 16(9), 987-997.  
Windsor, P. M., Nicol, K. F., & Potter, J. (2004). A randomized, controlled trial of 
aerobic exercise for treatment- related fatigue in men receiving radical external beam 
radiotherapy for localized prostate carcinoma. Cancer, 101(3), 550-557. 
doi:10.1002/cncr.20378  
 58 
Wong, J. N., McAuley, E., & Trinh, L. (2018). Physical activity programming and 
counseling preferences among cancer survivors: A systematic review. International 
Journal of Behavioral Nutrition and Physical Activity, 15(1), 48. 
Yabroff, K. R., Lawrence, W. F., Clauser, S., Davis, W. W., & Brown, M. L. (2004). 
Burden of illness in cancer survivors: Findings from a population-based national 
sample. Journal of the National Cancer Institute, 96(17), 1322-1330.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 59 
 
Chapter 3 
 
Improving Prostate Cancer Survivorship: Building Community Partnerships 
through Physical Activity 
 
Laura Lavers1, Kevin Power1, Jonathan Greenland2, and Erin McGowan1 
 
1 School of Human Kinetics & Recreation, Memorial University of Newfoundland, St. 
John’s, Newfoundland, Canada 
 
2 Cancer Care Program, Eastern Health, St. John’s, Newfoundland, Canada 
 
 
Laura Lavers, BKin (Hons) 
Memorial University of Newfoundland 
230 Elizabeth Ave, St. John’s, NL, A1B 3X9 
 
Kevin Power, PhD 
Memorial University of Newfoundland 
230 Elizabeth Ave, St. John’s, NL, A1B 3X9 
 
Jonathan Greenland, MD 
Eastern Health 
300 Prince Phillip Dr., St. John’s, NL, A1B 3V6 
 
*Erin McGowan, PhD 
Assistant Professor 
Memorial University of Newfoundland 
230 Elizabeth Ave, St. John’s, NL, A1B 3X9 
 
*Corresponding Author 
 
 
 
 
 
 
 
 
 
 
 
 
 
 60 
Abstract 
 
Background: Physical activity (PA) has been shown to improve prostate cancer 
survivors physical functioning and quality of life (QoL). Purpose: To investigate the 
impact of a community-based PA program on the QoL, fitness, fatigue, strength, and 
physical functioning of prostate cancer survivors, with a secondary purpose to examine 
the program’s feasibility and sustainability. Methods: PROFit, a 12-week community-
based, supervised PA program was developed by reviewing the current PA and cancer 
literature, and through establishing partnerships with a cancer care program, community 
fitness facility, and university. Specifically, 15 prostate cancer survivors and their 
partners (N=4) were recruited to take part in the PA program, which consisted of strength 
(i.e., circuit training) and aerobic training. Survivors QoL, fatigue, prostate cancer 
specific symptoms, physical functioning, and PA levels were assessed at baseline, six and 
12-weeks. Program attendance and cost were recorded to determine feasibility and 
sustainability. Satisfaction surveys were administered to participants and partners at six 
and 12-weeks. Results: One-way repeated measures analysis of variance found 
significant increases in lower body strength across all time points and flexibility from 
baseline to 12 weeks. No significant improvements were found in upper body strength, 
agility, aerobic fitness, weekly moderate-vigorous PA, QoL, and fatigue; however, non-
significant increases in participant upper body strength, weekly moderate-vigorous PA, 
and agility were noted. Participants and partners reported a high level of satisfaction with 
the program, and program attendance and intervention costs were satisfactory. 
Conclusion: The PROFit program had a positive impact on prostate cancer survivorship. 
Due to the lack of evidence surrounding community-based PA programs in prostate 
cancer survivors, the PROFit program delivers valuable insight into the collaboration 
between hospitals, universities and community centers to provide prostate cancer 
survivors with a resource for improving survivorship (i.e., QoL, physical functioning) 
following treatment. 
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3.1 Introduction 
 
Prostate cancer is the most commonly diagnosed cancer in males in Canada, with 
21,300 new cases, and 4,100 deaths in 2017 (Canadian Cancer Society’s Advisory 
Committee on Cancer Statistics [CCSACCS], 2017). Treatments for prostate cancer 
improve survival, and have led to a 95% five-year relative survival ratio (CCSACCS, 
2017).  Unfortunately, cancer treatments are associated with varying acute, chronic, and 
late-appearing side effects that are detrimental to prostate cancer survivors physical 
functioning and quality of life (QoL; Krupski & Litwin, 2007; Resnick et al., 2013; 
Thorsen et al., 2008). Research has consistently shown that physical activity (PA) is 
beneficial for cancer survivors, and can alleviate many of the experienced side-effects 
(Ferrer, Huedo-Medina, Johnson, Ryan and Pescatello, 2010; Fong et al., 2012). 
Specifically, for prostate cancer survivors, PA has been found to improve health-related 
outcomes, such as cancer-related fatigue, decreasing fat mass, physical fitness (e.g., 
aerobic capacity and muscular strength), sexual dysfunction, urinary incontinence, and 
health-related QoL (Baumann, Zopf, and Bloch, 2012; Dahn et al., 2005; Gardner, 
Livingston and Fraser, 2013; Keogh & MacLeod, 2012; Phillips et al., 2015; Thorsen et 
al., 2008; Wolin, Luly, Sutcliffe, Andriole, and Kibel, 2010). Research has also 
established that PA following a prostate cancer diagnosis is associated with lower all-
cause mortality and prostate cancer specific mortality (Bonn et al., 2014; Kenfield, 
Stampfer, Giovannucci, and Chan, 2011). 
Despite these findings, many prostate cancer survivors (i.e., 29-30%) are 
insufficiently active (Thorsen et al., 2008), due in part to treatment-related side effects 
(Keogh et al., 2010). Barriers such as a lack of willpower and difficulty maintaining 
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exercise routines following a prostate cancer diagnosis have also been found to contribute 
to low activity levels (Keogh et al., 2014; Ottenbacher et al., 2011). These findings 
highlight the need for PA programming to enable prostate cancer survivors to increase 
their PA levels, and improve their overall health.  
Community-based PA and exercise programs have gained considerable attention 
in recent years (De Smedt, De Cocker, Annemans, De Bourdeaudhuij and Cardon, 2012; 
Haas & Kimmel, 2011; Murray et al., 2012; Rajotte et al., 2012). They model ‘real-world’ 
PA, have been found effective at increasing PA in cancer survivors (Cheifetz et al., 2014; 
Murray et al., 2012; Rajotte et al., 2012), and are a successful alternative to traditional PA 
programs that are offered in research or hospital settings (Cheifetz et al., 2014, Haas & 
Kimmel, 2011). From the limited studies exploring community-based PA interventions, 
the results have been promising; including demonstrating benefits such as decreased 
fatigue, improved physical functioning (i.e., flexibility and muscular strength), and 
overall health-related QoL (Foley, Barnes and Hasson, 2015; Irwin et al., 2017; Keats & 
Culos-Reed, 2008; Murray et al., 2012; Rajotte et al., 2012). Community-based PA 
programs are an example of how collaboration between a research facility, a cancer 
clinic, and a community institution can create opportunities for cancer survivors to 
increase their PA levels. Additionally, community-based PA programs implemented in a 
group-based setting have been found to provide social support among cancer survivors, 
and promote PA adherence (Haas & Kimmel, 2011; Keogh & MacLeod, 2012; Swartz et 
al., 2017).  
A successful example of a community-based PA program is CanWell; a 12-week 
exercise and education program based out of the YMCA for cancer survivors (Cheifetz et 
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al., 2014). The CanWell program demonstrated the benefits of implementing existing 
knowledge in cancer care and research into a ‘real-world’ approach to increase PA levels 
among cancer survivors. Significant improvements in participants’ health-related QoL 
and physical functioning were found upon completion of the program. Given these 
findings, it is important to understand what enables a community-based PA program to be 
successful and sustainable, and in turn, use this information to develop programming 
specific to prostate cancer survivors looking to increase their levels of activity and health. 
The purpose of this study was to examine the impact of PROFit, a community-
based PA program on the QoL, fitness, fatigue, strength, and physical functioning of 
prostate cancer survivors. The secondary purpose was to evaluate the feasibility, 
sustainability, and satisfaction of the PROFit program.    
3.2 Methods 
 
3.2.1 Participants and Procedures 
 
Ethical approval was obtained from the institutions Health Research Ethics 
Authority prior to participant recruitment. The study was a prospective, pre-post, cohort 
design. Participants were prostate cancer survivors’ between the ages of 19-80, who had 
successfully completed cancer treatment (i.e., radiotherapy, chemotherapy, surgery, 
hormonal therapy), and were eligible for exercise. Participants were cleared for PA using 
a pre-exercise screening tool called the Physical Activity Readiness Questionnaire (PAR-
Q+), or by their physician, if necessary. Participants were recruited through posters and 
brochures at local cancer clinics and hospitals, presentations to local support groups, 
referrals from oncologists, and by word of mouth. Interested participants met with the 
principal investigator and written informed consent was obtained prior to data collection. 
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In addition, partners (i.e., spouse, family or friend) were encouraged to accompany the 
participants if they wished to do so, and partake in the PA program to improve program 
adherence and social cohesion (Culos-Reed et al., 2010; Keogh & MacLeod, 2012; 
Mutrie et al., 2007). Partners also completed written informed consent, as well as the 
PAR-Q+ before beginning the PROFit program.   
Assessments were completed at baseline (prior to the initiation of the PROFit 
program), at week six and week 12. The baseline assessments included objective PA 
behaviour, anthropometric data, and functional fitness. Demographic and medical 
variables, QoL, fatigue, and cancer specific symptoms were measured through self-report 
questionnaires. All measures were reassessed at week six and week 12; excluding 
demographic and medical information. Participant’s partners did not complete the 
assessments or questionnaires; however, they did complete the PROFit program 
satisfaction survey, along with the participants at week six and week 12.  
3.2.2 Intervention  
 
The PROFit program was a 12-week group-based resistance and aerobic PA 
program performed at a community fitness facility. A 12-week program was chosen to 
improve the likelihood of detecting a change in QoL and physical functioning (e.g., 
Cheifetz et al., 2014; Rajotte et al., 2012). All PA sessions were supervised by the 
principal investigator (Certified Kinesiologist), kinesiology student volunteers, as well as 
a Certified Exercise Physiologist (CEP). The CEP was responsible for providing 
adaptations to exercises. Participants were asked to take part in two group-supervised PA 
sessions per week for weeks one to nine, followed by a tapering period of one supervised 
 65 
group PA session per week for weeks 10-12. The tapering was incorporated to encourage 
participants to become more independent with their PA sessions. 
Each supervised PA session was one hour in duration. The session began with a 
15-minute aerobic warm up, followed by 35-minutes of structured resistance training 
using bodyweight, resistance bands, and free-weight exercises (Campbell, Stevinson and 
Crank, 2012; Keogh & MacLeod, 2012). The resistance exercises were modified to 
account for any adverse effects of prostate cancer treatments, such as loss of bone density 
from hormone therapy (Buffart, Galvao, Brug, Chinapaw and Newton, 2014), and were 
organized into six stations, with two exercises per station (e.g., station one– bodyweight 
squats and lunges, station two– push-ups and chest fly). Participants were instructed to 
progress through stations one to six, in that order, and performed three sets of 12 
repetitions for each exercise. Resistance exercises targeted the major muscle groups, and 
specific exercises included bodyweight squats, lunges, chest press, chest fly, lateral 
shoulder raise, shoulder press, step-ups, lateral band walks, band scapular retractions, 
seated row, plank and crunches. When using the free weights and resistance bands, the 
resistance was increased only when the participant could successfully complete 12 
repetitions without difficulty. Participants recorded their progress in a personal logbook. 
At weeks one, five, and nine, the order and variations of exercises were altered to prevent 
familiarity and boredom. In addition, visual aids of each exercise were provided on folded 
boards at each station for clarification. The last five minutes of the PROFit program 
consisted of light static stretching to prevent muscle tightness and improve flexibility. 
Finally, each exercise session was followed by a half hour social gathering in a separate 
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space on site. Participants and their partners were encouraged to attend and light 
refreshments were provided.  
3.2.3 Measures 
 
 Demographic and medical information was assessed using self-report. Medical 
variables included date of diagnosis, cancer recurrence, and types of treatments 
completed (e.g., surgery, radiation therapy, chemotherapy, and/or hormone therapy). 
Demographic variables included age, marital status, current employment status, level of 
education, as well as weight, height and waist circumference to measure body 
composition and calculate body mass index (BMI).  
 The primary outcomes of this study included assessments of PA levels, QoL, 
fatigue, prostate cancer symptoms, fitness, and physical functioning. These outcomes 
were assessed using self-report and objective measures. QoL was assessed using the 
Short-Form-36 health survey (SF-36), a general health survey measuring eight multi-item 
dimensions (Jenkinson, Wright and Coulter, 1994). The SF-36 questionnaire is a 
validated tool for measuring general QoL, and has been used extensively in the general 
and clinical populations (Brazier et al., 1992; Mols, Vingerhoets, Coebergh and van de 
Poll-Franse, 2005).  
Prostate cancer symptoms were assessed using the Prostate Cancer Subscale of the 
Functional Assessment of Cancer Therapy (FACT-P; Esper et al., 1997; Segal et al., 
2003; Segal et al., 2009). Specifically, the final 12 questions of the FACT-P form include 
the Prostate Cancer Subscale (PCS), and addresses concerns specific to prostate cancer 
and its treatment. Fatigue was assessed using the Functional Assessment of Chronic 
Illness Therapy – Fatigue (FACIT-F), a 12-item questionnaire that measures self-reported 
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fatigue and its impact on daily activities and function (Webster, Odom, Peterman, Lent 
and Cella, 1999). Low scores on each of the QoL measures reflect a lower health-related 
QoL and concerns relating to prostate cancer and its treatments.  
Finally, fitness and function were assessed using the Seniors Fitness Test (SFT) 
and Six-Minute Walk Test (6-MWT). The SFT consists of 6 simple movement tests that 
measure functional fitness in older adults (Rikli & Jones, 2001). The chair sit-stand and 
arm curl quantify the number of full stands and bicep curls completed in 30 seconds, 
respectively. The chair sit and reach gauges the distance to/past (-/+) the toes of the 
extended leg with an outstretched hand, and the back-scratch test measures the distance 
between the hands as you try and touch them behind the back; a more negative number 
indicates decreased flexibility. The eight foot up-and-go clocks the duration it takes to 
walk 8-feet, circle an object, and return to a seated position. The 6-MWT measures 
functional aerobic capacity in older adults by using a submaximal test (Solway, Brooks, 
Lacasse and Thomas, 2001), and has been used in research to assess walking capacity in 
cancer survivors (Cheifetz et al., 2014).  
PA levels were objectively measured using the ActiGraph wGT3X-BT tri-axial 
accelerometer (ActiGraph, LLC, Pensacola, FL, USA), which has been found to be a 
valid and reputable tool for measuring PA behaviour (Santos-Lozano et al., 2013; Skotte, 
Korshoj, Kristiansen, Hanisch and Holtermann, 2014). Accelerometers provide 
quantitative information regarding activity counts, energy expenditure, and activity levels. 
The device is sensitive to low frequency movements in the range of 0.25-2.5 Hz– the 
common range in individuals. The device was programmed with the participants’ height, 
weight, and age, and given to them to wear on an elastic belt around their waist for seven 
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consecutive days, during waking hours, for a minimum of 10 hours per day (Trost, 
McIver and Pate, 2005). Participants’ were instructed to remove the device only when 
showering or for water activities, as the device is not waterproof. Data was collected at 
baseline, week six and week 12, and was analyzed using the ActiLife software (version 
6.11.9). The Troiano Adult cut points for moderate-vigorous physical activity (MVPA) 
were used in this study (Troiano et al., 2008), and classify sedentary behaviour as 0-99 
counts per minute (CPM), light activity as 100 - 2019 CPM, moderate as 2020 - 5998 
CPM, and vigorous as >5999 CPM.  
 Secondary endpoints included exploring the feasibility and sustainability of the 
PROFit program, as well as the satisfaction of participants and partners with their PROFit 
experience. To assess the adherence to the program, attendance was taken at each session. 
Reasons for absenteeism were collected from participants (e.g., illness, other 
commitments). The total cost of implementing the program (i.e., cost of facility space, 
volunteers, refreshments) was recorded to assess sustainability. Safety was assessed by 
incidents or near misses (e.g., falls, injuries), and were recorded using a daily log. 
Satisfaction with the program was assessed using a satisfaction survey, and was given at 
week six and week 12 of the PROFit program.  
3.2.4 Statistical Analysis 
 
Descriptive statistics were used for description of participants’ baseline 
demographics and medical characteristics. One-way repeated measures analysis of 
variance (ANOVA) was used to evaluate change in physical function, prostate cancer 
symptoms and health-related QoL over time (i.e., baseline, six weeks, and 12 weeks), 
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with Bonferroni corrections applied to adjust for multiple comparisons. Intention to treat 
analysis was used to account for missing data (Fisher, 1990).  
3.3 Results 
 
A total of 16 prostate cancer survivors were deemed eligible and consented to 
participate and completed the baseline assessments for the PROFit program between 
March and October 2015. Of these participants, two (12.5%) dropped out of the study due 
to issues with chronic medical conditions unrelated to cancer (i.e., rheumatoid arthritis 
and lower back pain), and 14 (87.5%) completed the six-week and final assessments 
during the program. Data from a total of 15 participants was analyzed, and intent-to-treat 
analysis accounted for data from one participant who completed baseline assessments, but 
had to drop out of the study due to health-related reasons. There were 14 participants and 
four partners that completed the six and 12-week satisfaction surveys. There were no 
exercise-related injuries that affected program completion. Participants ranged from 57-
77 years of age, and over half are married, retired, and have completed some level of 
post-secondary education. Baseline characteristics for all participants are presented in 
Table 1. 
3.3.1 Changes in Physical Functioning and Performance Measures 
 
 Of the 15 participants examined, significant improvements in lower body strength 
were found using the chair sit-stand test, Wilks’ Lambda = .37, F (2, 13) = 10.9, p < 
.05, η2 = .6. Post-hoc analysis revealed the number of completed chair sit-stands increased 
significantly between baseline and 6-week measurements (mean difference= 2.6; 95% CI 
= .6 to 4.6; p < 0.05), and baseline and 12-week measurements (mean difference= 2.5; 
95% CI = .8 to 4.2; p < 0.05). Significant improvements were also found for lower body 
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flexibility using the sit-and-reach test, Wilks’ Lambda = .62, F (2, 13) = 3.9, p < .05, 
η2=.4; however, post-hoc analysis did not find significant differences between each time 
measurement (see Table 3). As seen in Table 2, improvements in upper body strength 
(i.e., the arm curl test) and agility (i.e., the eight foot up-and-go test) were found from 
baseline to 12-weeks, but failed to reach significance. No significant improvements were 
noted for aerobic fitness (i.e., the 6-MWT) or upper body flexibility (i.e., the back-scratch 
test). 
3.3.2 Changes in Physical Activity Behaviour 
  
 Data from 15 participants was analyzed and PA behaviour was represented as the 
average minutes of MVPA per week. There were no significant changes in MVPA levels 
at either time point, Wilks’ Lambda = .95, F (2, 13) = 0.4, p = .7, η2 = .1. However, there 
was an increase in the weekly average of MVPA from baseline (M = 197.5 min/week) to 
week six (M = 221.3 min/week, +23.9 min/week, 12.1% increase), with similar levels of 
MVPA reported at week 12 (M = 219.2 mins/week, -2.1 min/week, 1.0% decrease).  
3.3.3 Self-report health-related QoL measures 
  
 There were no significant improvements in the SF-36 physical component 
summary, Wilks’ Lambda = .84, F (2, 13) = 1.2, p = .3, η2 =.2, SF-36 mental component 
summary, Wilks’ Lambda = .93, F (2, 13) = 0.5, p = .6, η2 =.1, FACT-P, Wilks’ Lambda = 
.92, F (2, 13) = .6, p = .6, η2 =.1, and FACIT-F, Wilks’ Lambda = .71, F (2, 13) = 2.6, p = 
.1, η2 = .3 reported by participants throughout the PROFit program. In addition, post-hoc 
analysis showed no significant improvement in both components of the SF-36, the FACT-
P, or the FACIT-F (as seen in Table 3) at each time measurement.  
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3.3.4 Sustainability & Feasibility: Intervention Adherence, Cost, and Satisfaction 
  
Participants (N = 15) attended on average 68% of sessions during the PROFit 
program; ranging from 14.3% to 100% of sessions. When we eliminate the single 
participant included using intent-to-treat analysis, average group attendance (N = 14) rises 
to 71%. Missed sessions (N = 15) were accounted for and most often due to other 
commitments, such as family/volunteer events and out of town vacations (17%), illness 
(10%), and employment-related obligations (5%).  
The total cost to run the PROFit program was $3,556.60. The 12-week program 
was completed twice for this study, meaning each run-through cost $1,778.30, or 
alternatively $254.04 per person. Fees included facility space and equipment rental, 
snacks and light refreshment, and monetary compensation to the CEP and student 
volunteers who assisted with the PROFit program.  
At six and 12 weeks, 14 participants and four partners completed the PROFit 
program satisfaction survey. At week six, 93% of participants reported being ‘very 
satisfied’ with the organization and location of the program, the exercises, guidance from 
instructors, and encouragement from others, while 86% and 79% of participants felt ‘very 
satisfied’ with the duration of the program sessions and the group setting, respectively. 
From week six to week 12, 79% of participants stated they were ‘very satisfied’ with 
experiencing reduced levels of fatigue, which increased from 50% at week 6, and 93% of 
participants identified that they were ‘very satisfied’ with the group setting, which was up 
from 79% at week 6. In addition, 79% of participants stated they were ‘very satisfied’ 
with the social gatherings following the exercise session at both time points. Finally, the 
percentage of participants that reported being ‘very satisfied’ with the location of the 
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program, the variation of exercises completed, and feeling encouraged to participate in 
the program increased to 100% from week six to week 12. 
3.4 Discussion 
 
The primary goal of PROFit was investigating the effectiveness of a 12-week 
community-based PA program on the QoL, fitness, fatigue, strength, and physical 
functioning of prostate cancer survivors. Significant benefits in lower body strength and 
flexibility were found, and improvements in agility, upper body strength, aerobic fitness, 
and weekly MVPA were also found, however were not significant. Despite the lack of 
significance, these findings are comparable to benefits in physical functioning (i.e., 
muscular strength and flexibility) and PA levels found in other studies involving group-
based PA and prostate cancer survivors (Keogh & MacLeod, 2012), and supports the use 
of PA following prostate cancer treatments. Furthermore, the results of each physical 
performance measured at baseline, six weeks, and 12 weeks, fell within the normal range 
of scores for men between the ages of 65-80 (Jones & Rikli, 2002), and objectively 
measured PA levels at each time point satisfied the recommended minimum of 150 
mins/week of MVPA for older adults (Canadian Society of Exercise Physiology, 2011). 
This supports the possibility that sufficient levels of PA may have already been present in 
participants prior to beginning the PROFit program, limiting the potential of the program 
to improve their PA behavior.  
Unlike previous research that found significant enhancements in prostate cancer 
survivors QoL following increases in their PA (Phillips et al., 2015; Segal et al., 2003; 
Thorsen et al., 2008), there were no significant improvements in any QoL measures in 
this study. However, not all PA studies demonstrate major improvements in cancer 
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survivors QoL (Ferrer et al., 2010). Possible explanations include the considerable length 
of time (average of six years) between participants’ cancer diagnosis and the beginning of 
the PROFit program, as well as a higher physical component score (56.57) and a similar 
mental component score (51.31) in the SF-36 at baseline compared to Canadian men aged 
65-74 averaging 48.1 and 54.6, respectively (Hopman et al., 2000). Like the SF-36, 
results found for prostate cancer specific QoL outcomes were greater than anticipated. 
PROFit participants reported an average FACT-P score of 39.1 at baseline; a greater 
value than post-test participant scores (37.7 and 37.8) in a study by Segal et al. (2009) 
using the same questionnaire. These findings are similar to the PA level outcome 
measure, where baseline values were higher than anticipated, affecting the impact of the 
intervention on participant outcomes. Finally, no statistically significant improvements in 
participant fatigue levels were found (see table 2), however a greater percentage of 
participants expressed feeling “very satisfied” with experiencing reductions in their level 
of fatigue from week six (50%) to week 12 (79%) as noted in the satisfaction survey. 
Despite the limited improvement in QoL, PA levels, and some physical functioning 
components, the high satisfaction rate with the organization and location of the program, 
and overall program design, suggests participants enjoyed attending the PROFit program 
each week; an important component of any successful PA program. 
Other aspects of PROFit examined included program feasibility and sustainability, 
and participant satisfaction. Given the success of previous PA programs using a 
community-based approach (Cheifetz et al., 2014; Haas & Kimmel, 2011; Leach, 
Danyluk and Culos-Reed, 2014; Rajotte et al., 2012), the design of PROFit followed a 
similar layout. High satisfaction was reported for the organization and location of 
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PROFit, as well as the types of exercises completed by participants. More importantly, 
93% of participants reported enjoying the group exercise setting, and 79% enjoyed the 
social gatherings after each PROFit session, suggesting participants felt greater social 
supports and comradery throughout the program. Program feasibility was promoted 
through satisfaction with the design of PROFit, program adherence, recruitment, cost to 
run the program, and the cooperation of cancer clinics, physicians, and the fitness facility. 
Participant attendance was satisfactory, with 80% of participants attending over half of 
the exercise sessions, despite the limited session times offered during each week. Similar 
scheduling challenges and adherence rates were reported by Rajotte et al. (2012), 
acknowledging the benefit of such community-based programs, and the need for 
additional classes for program development. Furthermore, PROFit was funded by the 
Eastern Health Lighthouse Grant, which covered the per person cost of $254.04. The lack 
of financial commitment for participants positively affected study recruitment; 
unfortunately, specific details to analyze recruitment rates are not available due to the 
variety of methods employed. To promote long-term sustainability of the program, a 
small fee could be administered to participants that wish to continue the program past the 
initial 12-weeks. This could offset some of the financial burden of overhead costs to run 
the program without deterring prostate cancer survivors’ involvement. Participants may 
be more inclined to contribute to the financial necessities of a PA program if given the 
opportunity to benefit from improvements in physical functioning and QoL shown to 
occur in the first 12 weeks (Cheifetz et al., 2014). The cost-effectiveness to run the 
program, and the successful collaboration with the community fitness facility in 
delivering the program, fostered sustainability.  
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Much like the CanWell program (Cheifetz et al., 2014), PROFit has valuable 
components necessary for a sustainable method of enhancing prostate cancer survivors 
physical functioning and QoL, and its design was modeled after the CanWell program. In 
a follow-up study of CanWell (Cheifetz et al., 2015), researchers discovered that 85% of 
CanWell participants continued to exercise (on average) 29 months after program 
completion, and 68% of participants renewed their membership at the YMCA where 
CanWell was held. The researchers determined that familiarity with the fitness facility 
and exercise routines had a positive impact on PA adherence, unlike PA interventions 
held in research facilities with limited opportunity for PA continuation. These findings 
highlight the importance of a sustainable and feasible community-based PA program 
designed to encourage prostate cancer survivors to participate in PA.  
The strengths of this study include the community-based design (i.e., 
collaboration between a research facility, cancer care center, and community fitness 
facility); the group-based, ‘real world’ setting appeared to promote participant comradely 
and adherence, as well as the focus on prostate cancer survivorship and treatment side 
effects, specifically. To our knowledge, this is the first study to examine the relationship 
between community-based PA and prostate cancer survivorship. However, one of the 
main challenges of this study was recruitment of prostate cancer survivors. Despite 
frequent contact with cancer clinics, oncologists, support group meetings, and word of 
mouth, recruitment was challenging, and resulted in a lower sample size than desired. The 
small sample size had a direct effect on the inability of the study to detect differences in 
physical functioning, QoL and PA levels. Future research could benefit from targeted 
strategies to increase participant recruitment to improve statistical power, such as using a 
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computerized alert system to identify potential participants to the referring physician, or 
delegating a specific research assistant staff member with the sole responsibility of 
participant recruitment (Preston et al., 2016). In addition, changes in program design 
could be modified to improve outcomes, such as offering alternative or additional 
exercise classes to accommodate participant attendance; an issue identified by 
participants as reasons for missed sessions. An additional study limitation is the lack of a 
control group. The inclusion of a control could provide a comparison between groups 
about the effect of the PA intervention on all outcomes. Finally, the social support 
systems in other community-based programs could be measured, and its relationship to 
participant adherence examined. 
In summary, the PROFit program has been shown to be a feasible and sustainable 
community-based PA program, and has been successful in encouraging prostate cancer 
survivors to engage in PA in a safe and supportive environment to improve and/or 
maintain the beneficial effects (i.e., physical functioning, QoL) associated. Participants 
within the study did not exhibit significant improvements in QoL and fatigue reduction as 
anticipated by our research hypotheses; however, there was some benefit in aerobic 
fitness and muscular strength noted. Also, participant satisfaction with the PROFit 
program was high, supporting the necessity of such community-based programs by 
prostate cancer survivors. Our findings highlight the need for alternative methods of 
improving PA levels in prostate cancer survivors, given the benefits to treatment-related 
side effects following increases in PA (Thorsen et al., 2008). Community-based PA 
programs, such as PROFit, will allow prostate cancer survivors to re-connect with their 
community, and use PA programming to improve survivorship and disease outcomes.  
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Table 1. Participant characteristics at baseline 
Variable Overall (N = 16) 
Demographics 
Age (years) 
Mean 
SD 
Range 
 
 
68.1 
5.7 
57-77 
Married (No. (%)) 14 (85.7%) 
Education 
     Completed University/College  
 
14 (85.7%) 
Work Status 
     Retired 
 
12 (75.0%) 
Ethnicity 
     Caucasian 
 
16 (100.0%) 
Medical  
     Weight, kilograms 
        Mean 
        SD 
 
88.6 
12.2 
     Height, meters 
        Mean 
        SD 
 
1.7 
0.0 
     BMI (kg/m2) 
        Mean 
        SD 
 
29.2 
3.6 
     Waist circumference, inches 
        Mean 
        SD 
 
40.6 
3.9 
      Time since diagnosis, months 
        Mean 
        SD 
 
                          72.3 
39.2 
      Treatment 
        Surgery 
        Radiation 
        Hormone Therapy 
 
10 (62.5%) 
9 (56.3%) 
1 (6.3%) 
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Table 2. Physical function and health-related quality of life outcomes 
Variable Pre-PROFit 6 weeks 12 weeks  
Mean (SD) Mean (SD) Mean (SD) Partial eta squared 
Physical Measures (n = 15)     
     Arm curl 21.9 (6.7) 25.0 (5.9) 25.3 (5.9) 0.3 
Chair sit-stand 13.1 (2.7) 15.7 (4.3)**+ 15.6 (3.2)**++ 0.6 
Chair sit and reach (inches) 2.2 (3.8) 2.3 (3.2) 3.1 (3.3)*++ 0.4 
Back scratch (inches) -6.4 (5.1) -7.2 (5.1) -7.5 (4.9) 0.2 
Eight foot up-and-go (seconds) 00:06.32 
(00:01.22) 
00:05.96 
(00:00.81) 
00:05.94 
(00:00.88) 
0.2 
6MWT (yards) 584.4 (70.4) 587.6 (77.5) 577.1 (68.6) 0.1 
QoL Measures (n = 15)     
SF-36 (PCS) 56.5 (3.7) 53.8 (6.6) 54.6 (4.8) 0.2 
SF-36 (MCS) 51.3 (4.3) 52.3 (4.7) 51.7 (6.0) 0.1 
FACT-P 39.1 (4.7) 40.3 (6.1) 39.5 (5.8) 0.1 
FACIT-F 48.0 (4.7) 46.4 (5.0) 48.5 (3.1) 0.3 
PA Measures (n = 15)     
Objectively measured MVPA 
(mins/week) 
197.5 (159.8) 221.3 (158.6) 219.2 (187.3) 0.1 
SD, standard deviation; 6-MWT, 6-min walk test; SF-36 (PCS), 36-item short form survey (physical component summary); SF-36 (MCS), 
36-item short form survey (mental component summary); FACT-P, Functional Assessment of Cancer Therapy Scale-Prostate; FACIT-F, 
Functional Assessment of Chronic Illness Therapy-Fatigue; MVPA, moderate-to-vigorous physical activity. 
Significant improvements compared with baseline. 
Wilk’s Lambda values are reported in this table. 
*p < 0.05 
**p < 0.01 
+ indicates pre-test to 6 weeks 
++ indicates pre-test to 12 weeks 
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Table 3. Data comparisons between baseline, 6-week, and 12-week time measurements 
Variable MD 95% CI p-value* 
Physical Measures    
Armcurl (n = 15)    
Armcurl1 vs Armcurl2 -3.1 -6.5 to 0.4 0.1 
Armcurl1 vs Armcurl3 -3.4 -6.9 to 0.2 0.1 
Armcurl2 vs Armcurl3 -0.3 -2.4 to 1.7 1.0 
Chair sit-to-stand (n = 15)    
Chair1 vs Chair2 -2.6 -4.6 to -0.6 0.0 
Chair1 vs Chair3 -2.5 -4.2 to -0.8 0.0 
Chair2 vs Chair3 0.1 -2.2 to 2.5 1.0 
Sit and reach (n = 15)    
Sitandreach1 vs Sitandreach2 -0.0 -1.3 to 1.2 1.0 
Sitandreach1 vs Sitandreach3 -0.9 -1.9 to 0.2 0.1 
Sitandreach2 vs Sitandreach3 -0.9 -1.9 to 0.2 0.1 
Back scratch (n = 15)    
Backscratch1 vs Backscratch2 0.7 -1.0 to 2.5 0.8 
Backscratch1 vs Backscratch3 1.1 -0.7 to 3.0 0.4 
Backscratch2 vs Backscratch3 0.4 -0.6 to 1.3 1.0 
Eight-foot-up-and-go (n = 15)    
Eight1 vs Eight2 0.4 -0.2 to 0.9 0.2 
Eight1 vs Eight3 0.4 -0.2 to 1.0 0.4 
Eight2 vs Eight3 0.0 -0.3 to 0.4 1.0 
6-MWT (n = 15)    
6-MWT1 vs 6-MWT2 -3.2 -39.1 to 32.7 1.0 
6-MWT1 vs 6-MWT3 7.3 -25.9 to 40.5 1.0 
6-MWT2 vs 6-MWT3 10.5 -18.7 to 39.8 1.0 
Objectively measured MVPA 
(mins/week; n = 15) 
   
Baseline vs 6-weeks -25.6 -104.9 to 53.8 1.0 
Baseline vs 12-weeks -23.3 -128.7 to 82.1 1.0 
6-weeks vs 12-weeks 2.3 -72.2 to 76.8 1.0 
QoL Measures    
SF36-PCS (n = 15)    
SF36-PCS1 vs SF36-PCS2 2.8 -2.2 to 7.8 0.5 
SF36-PCS1 vs SF36-PCS3 1.9 -2.1 to 5.8 0.7 
SF36-PCS2 vs SF36-PCS3 -0.9 -5.4 to 3.7 1.0 
SF36-MCS (n = 15)    
SF36-MCS1 vs SF36-MCS2 -1.0 -4.3 to 2.3 1.0 
SF36-MCS1 vs SF36-MCS3 -0.4 -5.7 to 4.9 1.0 
SF36-MCS2 vs SF36-MCS3 .62 -2.9 to 4.1 1.0 
FACT-P (n = 15)    
FACT-P1 vs FACT-P2 -1.1 -4.4 to 2.2 1.0 
FACT-P1 vs FACT-P3 -0.3 -4.3 to 3.6 1.0 
FACT-P2 vs FACT-P3 0.8 -2.2 to 3.8 1.0 
FACIT-F (n = 15)    
FACIT-F1 vs FACIT-F2 1.6 -0.6 to 3.8 0.2 
 89 
FACIT-F1 vs FACIT-F3 -0.5 -3.3 to 2.4 1.0 
FACIT-F2 vs FACIT-F3 -2.1 -4.9 to 0.8 0.2 
MD, Mean difference; CI, Confidence interval; 6-MWT, 6-min walk test; SF36-PCS, 36-item 
short form survey - physical component summary; SF36-MCS, 36-item short form survey-
mental component summary; FACT-P, Functional Assessment of Cancer Therapy Scale-
Prostate; FACIT-F, Functional Assessment of Chronic Illness Therapy-Fatigue. 
*p-values were adjusted with Bonferroni correction for multiple comparisons. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
